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OVERVIEW 
 
This thesis consists of three parts: a systematic literature review, an empirical paper 
and a critical appraisal. It aims to contribute to the evidence base for psychological 
interventions for Tourette Syndrome (TS). TS is a neurodevelopmental condition 
characterised by the presence of both motor and vocal tics. Tics typically first 
present in childhood and are associated with psychiatric co-morbidity, social and 
emotional difficulties, impaired school functioning and a diminished quality of life. 
 
The literature review explores the efficacy and effectiveness of currently available 
psychological interventions for TS. It reviews both traditional behavioural 
approaches as well as newer adaptations of existing treatment protocols. 
 
The empirical paper evaluates the long-term outcomes of two group treatments 
(Comprehensive Behavioural Intervention for Tics and psychoeducation) for children 
with TS. It assesses the effect of these treatments on tic severity, 
neuropsychological functioning, quality of life and school attendance. 
 
Finally, the critical appraisal reflects on the process of conducting the research 
study. Specifically, it comments on the unique advantages and disadvantages of 
joining a larger research project, further explores the strengths and limitations of the 
study’s methodology and finally reflects on the experience of working with children 
with a neurodevelopmental disorder. 
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ABSTRACT 
 
Aims 
This review aims to summarise and evaluate the empirical support for currently 
available psychological interventions for Tourette syndrome (TS). 
 
Method 
A systematic search of three databases (Embase, PsychINFO and Ovid Medline) 
was conducted and a narrative synthesis of the data was reported. 
 
Results 
Sixteen citations were identified for inclusion in the review, consisting of both 
controlled and uncontrolled trials of psychological interventions for TS. Interventions 
included established behavioural treatments and cognitive behaviour therapy (CBT), 
as well as third wave CBT approaches and adapted behavioural protocols utilising 
novel treatment delivery methods. 
 
Conclusions 
Treatment efficacy was reported across the range of psychological interventions, 
with traditional behavioural methods demonstrating the greatest treatment 
response. Newer approaches which address practical issues such as limited 
clinician availability will require high quality evaluation before conclusions about ‘a 
best approach’ can be made. 
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1. INTRODUCTION 
 
Diagnosis and epidemiology 
 
Tics are sudden, involuntary and repetitive movements or vocalisations. They are 
considered neurodevelopmental in nature and tend to wax and wane with time. A 
diagnosis of Tourette syndrome (TS) may be given where two or more motor tics 
and at least one vocal tic occur consistently or on and off for a period of one year. 
Where only motor or vocal tics are present, a diagnosis of chronic tic disorder (CTD) 
may be offered (American Psychiatric Association, 2013).  Diagnostic criteria are 
similar in the International Classification of Diseases, 10th Revision (ICD-10; World 
Health Organisation, 1992). This review will refer to both chronic tic disorders and 
Tourette syndrome, collectively (TS), as it summarises and evaluates the research 
evidence supporting psychological interventions for tic disorders. 
 
Tourette Syndrome has an estimated prevalence rate of approximately 1% amongst 
5-18 year olds (Robertson, 2008) with prevalence higher amongst males than 
females (Knight et al., 2012). Comorbid psychiatric disorders are common amongst 
individuals with TS, with co-occurrence rates for attention deficit hyperactivity 
disorder (ADHD) and obsessive compulsive disorder (OCD) typically ranging 
between 25% and 50% (Abramovitch, Dar, Mittelman & Wilhelm, 2015). Tourette 
Syndrome and its comorbidities have also been associated with poor quality of life 
(Storch et al., 2007) and more recent psychological interventions have placed a 
focus on the management of these adverse psychosocial effects. 
 
Psychopharmacotherapy 
 
15 
 
Traditionally, drugs such as antipsychotics (risperidone, haloperidol and pimozide) 
and alpha-2 agonists (guanfacine and clonidine) have been used in the 
management of tic disorders. Weisman, Qureshi, Leckamn, Scahill and Bloch 
(2013) conducted a meta-analysis of five randomised, placebo-controlled trials 
evaluating the efficacy of these drug treatments. Results found a significant 
treatment effect (standardised mean difference = 0.58) for antipsychotics compared 
to placebo. A modest treatment effect for alpha-2 agonists was also found, however 
subgroup analysis of the stratified data found this effect to be significant only for 
participants with comorbid ADHD symptoms. These findings suggest that certain tic 
medication may not be suitable or effective for all TS patients. Antipsychotics have 
also been associated with unpleasant side effects such as restlessness, weight gain 
and depression (Scahill et al., 2006), and it has been estimated that as much as 
80% of individuals discontinue use of TS medication due to unwanted side effects 
(Peterson, Campise and Azrin, 1994). 
 
Furthermore, whilst drug treatment may significantly reduce certain tic symptoms, 
some tics may persist and without adequate learned coping mechanisms, may 
remain bothersome. For individuals with symptoms that do not respond to drug 
treatment or for those that struggle with the unpleasant side effects of medication, 
psychological treatment may prove to be a more viable and sustainable option. 
 
Behavioural interventions 
 
Literature on the efficacy of psychological interventions for tics spans several 
distinct behavioural models which have followed the chronology of treatment in 
other disorders such as depression and anxiety. Historically, these have included 
operant conditioning models involving contingency management methods (Roane, 
Piazza, Cercone, & Grados, 2002), as well as Massed Negative Practice (MNP). 
16 
 
MNP is an approach that involves the deliberate voluntary repetition or ‘over-
rehearsal’ of target tics with the aim of promoting muscle fatigue, leading to the 
reduction of tic expression (Franklin, Walther & Woods, 2010). These behavioural 
approaches have largely been trialled and documented within single case studies 
(Nicassio, Liberman, Patterson, Ramirez, & Sanders, 1972; Wagaman, 
Miltenberger, & Williams, 1995) with few controlled, experimental trials undertaken. 
The most commonly evaluated and arguably most widely applied behavioural 
approach to date is Habit Reversal Training (HRT). Developed and first proposed by 
Azrin and Nunn (1973), HRT consists of self-monitoring components and 
awareness building as well as relaxation and competing response training (Azrin & 
Peterson, 1988, cited in Dutta & Cavanna, 2013). It aims to attune the patient’s 
awareness to the premonitory urge, a sensory experience that signals the onset of a 
tic. The patient is then taught to inhibit the production of the tic when they notice the 
premonitory urge by applying an incompatible movement, vocalisation or breathing 
pattern that inhibits the tic. These tic blocking gestures are referred to as ‘competing 
responses’. Several randomised controlled trials (RCTs) have demonstrated 
significant improvement in tic symptoms following a course of HRT when compared 
to supportive psychotherapy treatment (Deckersbach, Rauch, Buhlmann and 
Wilhelm, 2006; Wilhelm et al., 2003). HRT has also been found to achieve greater 
reductions in tics compared to MNP (Azrin, Nunn & Frantz, 1980). 
 
Exposure and Response Prevention (ERP) was developed as an ‘extension to habit 
reversal’ (Verdellen, Keijsers, Cath & Hoogduin, 2004). ERP encourages exposure 
to the premonitory urge that precedes the tic whilst suppressing the tic for as long 
as the patient feels able to. Suppression time is gradually extended during and 
beyond treatment. The approach is designed to promote habituation to the urge, 
reducing the subjective intensity of the premonitory urge and consequently, 
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increasing the length of time the patient is able to suppress the tic. Treatment 
effects of ERP have been found to be comparable to that of HRT (Verdellen et al., 
2004). 
 
Newer studies have applied an adapted behavioural protocol that combines several 
of the above-mentioned behavioural techniques including habit reversal training, as 
well as psychoeducation, contingency management, behavioural rewards and 
function-based interventions. This combination of behavioural techniques is referred 
to as a ‘Comprehensive Behavioural Intervention for Tics’ (CBIT; Himle et al., 2012) 
and has been associated with positive treatment outcomes in both children 
(Piacentini et al., 2010) and adults (Wilhelm et al., 2012). 
 
McGuire et al.’s (2014) meta-analysis reviewed the efficacy of behavioural 
interventions for TS including HRT, ERP and CBIT treatment trials. Overall, a 
medium to large treatment effect of behaviour therapy was identified (standardised 
mean difference = 0.67), comparable to that of antipsychotic medication. 
 
Cognitive behavioural interventions 
 
During the 2000s, an emphasis was placed in research studies on cognitive 
elements of treatment. CBT includes treatment components such as cognitive 
restructuring alongside standard behavioural techniques. Cognitive restructuring 
involves identifying and adapting patients’ expectations and behavioural patterns in 
‘high tic risk situations’, described by O’Connor (2005) as specific times or places 
where tics have been observed to occur more frequently (e.g. at the end of the day). 
Other CBT approaches, such as Storch et al.’s (2012) ‘Living With Tics’ (LWT) 
protocol have employed cognitive restructuring tools to target distorted beliefs about 
18 
 
the meaning of having tics and the impact they have on the patient’s everyday life 
with the aim of improving quality of life outcomes (Storch et al., 2012). Several 
studies have demonstrated positive treatment outcomes from Cognitive Behaviour 
Therapy (CBT) for TS (Morand-Beaulieu, O’Connor, Sauvé, Blanchet & Lavoie, 
2015; O’Connor et al., 2001). 
 
The cognitive behavioural approach to tic management has paved the way for the 
development of protocols based on third wave CBT methods. Reese et al. (2015) 
demonstrated the feasibility of a mindfulness-based stress reduction treatment 
aimed at targeting tic-related anxiety and frustration, whilst Franklin, Best, Wilson, 
Loew and Compton (2011) adapted an HRT protocol to include Acceptance and 
Commitment Therapy (ACT) components that aimed to promote the acceptance of 
tic-related urges. They found that this combined approach demonstrated 
comparable effectiveness to HRT. 
 
Challenges and future directions for psychological interventions 
 
Despite the positive outcomes associated with psychological interventions for TS, 
treatment is not widely available or accessible due to the limited number of trained 
practitioners (McGuire et al., 2015). To address this problem, several novel 
treatment delivery approaches have been developed. The structured, component-
based nature of CBIT has allowed for its adaptation for alternative treatment 
delivery models such as telemedicine (Himle, Olufs, Himle, Tucker & Woods, 2010; 
Himle et al., 2012; Ricketts, Bauer, Ran, Himle & Woods, 2014) and as an intensive 
outpatient  treatment package (IOP; Blount, Lockhart, Garcia, Raj & Peterson, 
2014). IOP uses a combination of intensive, week-long, face to face sessions as 
well as telehealth-facilitated follow up appointments to overcome the challenges of 
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treatment availability for families in remote locations. Preliminary findings from a 
small-N case series demonstrated significant reductions in tic severity following IOP 
treatment, which were maintained at 6-7 month follow up (Blount et al., 2014). In 
addition, delivery by non-therapist health professionals such as school 
psychologists (Clarke, Bray, Kehle & Truscott, 2001), occupational therapists 
(Rowe, Yuen & Dure, 2013), and physicians and nurse practitioners (Ricketts et al., 
2015a) further aims to widen the availability of behavioural treatment for TS. 
 
This systematic review evaluates the quality of the research evidence supporting 
the currently available range of psychological interventions for tic disorders. 
 
 
2. METHOD 
 
2.1 SEARCH METHODOLOGY 
2.1.1 Electronic search strategy 
An electronic search was conducted to identify relevant peer-reviewed journal 
articles. Using Ovid, the search was run simultaneously on the following databases: 
Embase (1974 to 2015 October 16), PsychINFO (1806 to October Week 2 2015) 
and Ovid Medline (1946 to October Week 2 2015). 
Search terms were determined by an initial look at the existing literature and 
preliminary ‘trial’ searches. The original search terms were then refined to ensure 
that the search strategy was both appropriately specific and sensitive. The following 
search terms were used: “Tourette* OR tic OR tics” featured in the title AND 
“behavio* OR mindfulness OR acceptance OR cognitive” featured as a keyword 
AND “treatment OR therapy OR intervention” featured as a keyword. Results were 
limited to the English language and to human subjects. 
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This search strategy produced 1583 citations, 597 of which were identified as 
duplicates and excluded using the Ovid ‘De-duplicate’ tool (see Figure 1 for flow 
diagram illustrating study selection process). 
2.1.2 Citations from other sources 
Four additional citations were identified for inclusion through personal 
correspondence with authors of the already included citations. This allowed for 
inclusion of very recently published articles and those that had been accepted for 
publication and were ‘in press’. 
2.2 SELECTION OF STUDIES 
A preliminary review of the titles and abstracts led to the exclusion of 948 citations 
that were not specifically studying TS/CTD, did not focus on the effectiveness of a 
psychological intervention, or were not a treatment trial. The remaining 42 citations 
underwent a more detailed full text evaluation and 26 were excluded on the basis of 
study design issues which included duplicated samples, small sample case series 
that did not offer aggregated outcome data and the absence of a tic severity 
outcome measure. The remaining citations underwent a critical appraisal of 
methodological factors. Studies were scored using a point system developed from a 
combination of several existing critical appraisal tools (Centre for Evidence-based 
Medicine; Critical Appraisal Skills Programme, 2013; Evidence-Based Behavioral 
Practice; Health Evidence Bulletins, Wales; The Cochrane Risk Of Bias Assessment 
Tool for Non-Randomized Studies of Interventions; The Scottish Intercollegiate 
Guidelines Network). A set of questions relating to study quality that were deemed 
relevant to the aims of this review were compiled from these existing quality 
assessments. Points were awarded for each quality factor that was fulfilled by a 
study, with a maximum of 17 points available. Quality criteria were split into three 
categories: methodological factors, statistical factors and confounding factors. 
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Points were awarded according to the following quality criteria:  
 description of intervention;  
 use of control group;  
 group allocation process;  
 characteristics of the evaluator;  
 suitability and validity of measures;  
 reporting of inclusion and exclusion criteria;  
 reporting of demographic data;  
 representative sample;  
 reporting of outcome data including estimates of random variability;  
 considerations of sample size and power analysis;  
 use of statistical correction for multiple statistical tests;  
 consideration of potential confounding variables and correction for these. 
Five citations were excluded from the systematic review on the basis of a low 
appraisal score. The cut-off appraisal score for inclusion was set at ‘eight or above’ 
which was determined when reading each paper in full independent of the technical 
assessment and noting that each paper identified as having significant study design 
issues had scored seven or less points during the critical appraisal. 
 
2.3 DATA MANAGEMENT 
 
2.3.1 Data extraction 
Personal correspondence was made with eight authors of included articles to either 
acquire the full text of the article or to check whether subject samples were unique 
to the study where this was not clear. 
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Data from each study was inputted into a standardised table. Data included the 
following information: 
 sample size; 
 demographics;  
 comorbidity data; 
 medication status; 
 treatment type; 
 number of treatment sessions; 
 control group; 
 outcome measures; 
 critical appraisal score. 
2.3.2 Data synthesis 
Due to the inclusion of both controlled and non-controlled study designs, a narrative 
data synthesis approach was used. 
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Figure 1. Study selection and rationale for exclusion 
 
 
 
 
1583 Citations identified from systematic search 
597 Duplicate citations removed 
using Ovid ‘De-duplicate’ tool 
42 Citations Identified for Detailed Evaluation 
16 Citations Included in Systematic Review 
948 Citations Excluded 
20 Further duplicates 
4 Not human 
25 Not specifically studying TS/CTD     
only 
594 Not focusing on the 
effectiveness of a psychological 
intervention 
299 Not a treatment trial 
6 Full text not available 
21 Citations Excluded 
7 Citations from same sample 
14 Methodological/design 
issues 
 
990 Citations Identified for Preliminary Review 
4 Additional citations 
identified from other 
sources 
5 Citations Excluded 
5 Did not meet critical appraisal 
minimum criteria 
 
21 Citations Identified for Critical Appraisal 
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3. RESULTS 
 
3.1 SEARCH RESULTS 
Sixteen journal articles met inclusion criteria (see Table 1 for a full list of included 
studies). Articles were grouped into four main categories based on the type of 
psychological intervention they were investigating. Categories included: behavioural 
treatment (N=6), cognitive behavioural treatment (N=4), third wave cognitive 
behavioural treatment (N=2) and novel delivery modalities of behavioural treatment 
(N=4). 
3.2 DESCRIPTION OF STUDIES 
3.2.1 Outcome measures 
Most studies (N=14) used the Yale Global Tic Severity Scale (YGTSS; Leckman et 
al., 1989) as a primary outcome measure of tic severity. Other measures of tic 
severity included the Parent Tic Questionnaire (PTQ; Chang, Himle, Tucker, Woods 
& Piacentini, 2009) and the Adult Tic Questionnaire (ATQ; which is directly modelled 
on the PTQ), the Clinicians Global Impression – Improvement Scale (CGI-I; Guy, 
1976), the Clinicians Global Impression – Severity Scale (CGI-S; Guy, 1976), the 
Tic Symptom Hierarchy Tracker (TSHT; Woods, 2008), Subjective Units of Distress 
(SUDS; Woods, 2008), direct observation, Premonitory Urge for Tics Scale (PUTS; 
Woods, Piacentini, Himle & Chang, 2005), Tourette Syndrome Global Scale (TSGS; 
Harcherik et al., 1984), Child Tourette’s Syndrome Impairment Scale (CTIM-P; 
Storch et al., 2007a), and a daily tic diary. 
Aside from tic severity, studies also measured the impact of the intervention on 
quality of life/life satisfaction (Deckersbach et al., 2006; McGuire et al. 2015; Storch 
et al., 2012), psychosocial functioning (Deckersbach et al. 2006; McGuire et al. 
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2015; Morand-Beaulieu et al., in press; O’Connor et al. 2001; Piacentini et al. 2010, 
Storch et al., 2012), impulsivity (Morand-Beaulieu et al., 2015) work and social 
adjustment (Franklin et al., 2011; Reese et al., 2015) occupational performance 
(Rowe et al. 2013) and working alliance (Himle et al. 2012). 
3.2.2 Study samples 
Eight studies measured the efficacy of an intervention within a child/adolescent 
population only, six studies focused on an adult population only, and two studies 
included both adult and child subjects in their treatment trials. 
Sample populations were drawn from several different countries including the USA 
(12), Canada (2), The Netherlands (1) and Japan (1).
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Table 1 
Characteristics of Studies Included in Systematic Review 
Study N Mean 
age 
% male % with 
OCD 
% with 
ADHD 
% on tic 
medication 
Treatment Control 
group 
No. of 
sessions 
Outcome 
measures 
Critical 
appraisal 
score 
Critical 
appraisal 
rating 
             
 
Deckersbach 
et al., 2006 
 
 
 
35 
   
57% 
   
30% 
 
   
0% 
 
53% 
• 
(HRT) 
 
Supportive 
psycho-
therapy 
 
14 
 
YGTSS, 
CGI-I, SDI, 
SOS-10, 
VSP task 
 
14 ••• 
 
 
Franklin et 
al., 2011 
 
 
 
15 
   
85% 
   
8% 
   
46% 
 
 
 N/A 
• 
(HRT + 
ACT) 
 
HRT 
 
HRT + 
ACT = 
10, 
HRT = 8 
 
YGTSS, 
CGI-I, 
WSAS 
 
10 •• 
 
Himle et al., 
2012 
 
 
 
 
12 
   
94% 
   
22% 
   
28% 
 
28% 
• 
CBIT 
(Tele-
health) 
 
CBIT 
(Face to 
face) 
 
8 
 
YGTSS, 
CGI-S, CGI-
I, PTQ, WAI, 
TAQ 
 
13 ••• 
 
McGuire et 
al., 2015 
 
 
 
 
 
 
 
 
 
 
 
11 
   
75% 
   
38% 
   
42% 
 
54% 
• 
(LWT) 
 
Waitlist 
 
10 
YGTSS, 
CTIM-P, 
PedsQL, 
CY-BOCS, 
MASC 
 
15 ••• 
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Study N Mean 
age 
% male % with 
OCD 
% with 
ADHD 
% on tic 
medication 
Treatment Control 
group 
No. of 
sessions 
Outcome 
measures 
Critical 
appraisal 
score 
Critical 
appraisal 
rating 
             
 
 
Morand-
Beaulieu et 
al., 2015 
 
 
 
38 
 
   
65% 
 
   
0% 
 
   
5% 
 
 
10% 
• 
 
N/A 
 
14 
 
YGTSS, 
TSGS, BDI, 
BAI, VOCI, 
BIS-11 
 
9 • 
 
Nonaka et al., 
2015 
 
 
 
15 
 
   
71% 
 
   
0% 
 
   
0% 
 
 
100% 
• 
(CBIT) 
 
N/A 
 
8 
 
YGTSS, 
PUTS, 
SUDS 
 
9 • 
 
O'Connor et 
al., 2001 
 
 
 
39 
   
61% 
   
0% 
   
0% 
 
 
N/A 
• 
 
Waitlist 
 
12 
Daily tic 
diary, SSI, 
LES, STAI, 
BDI, GHQ, 
MOCI, EPI 
 
11 •• 
 
Piacentini et 
al., 2010 
 
 
 
12 
   
79% 
   
19% 
    
26% 
 
37% 
• 
(CBIT) 
Supportive 
therapy 
and 
education 
 
8 
 
YGTSS, 
PTQ, CGAS 
 
14 ••• 
 
Reese et al., 
2014 
 
 
 
35 
   
56% 
   
44% 
    
11% 
 
44% 
• 
(Mindful-
ness 
based 
stress 
reduction) 
 
N/A 
 
8 (+ 4hr 
retreat) 
 
YGTSS, 
CGI-I, ATQ, 
WSAS, 
FFMQ 
 
10 •• 
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Study N Mean 
age 
% male % with 
OCD 
% with 
ADHD 
% on tic 
medication 
Treatment Control 
group 
No. of 
sessions 
Outcome 
measures 
Critical 
appraisal 
score 
Critical 
appraisal 
rating 
             
 
Ricketts et 
al., 2015a 
 
 
 
12 
 
   
66% 
 
   
11% 
 
   
11% 
 
 
44% 
 
 
• 
(CBIT-NP) 
 
N/A 
 
6 
 
YGTSS, 
KBIT, CGI-S, 
CGI-I 
 
11 •• 
 
 
Ricketts et 
al., 2015b 
 
 
 
12 
 
    58% 
   
5% 
   
20% 
 
35% 
• 
(CBIT-
VoIP) 
 
Waitlist 
 
8 
 
YGTSS, 
MINI-Kid, 
WASI, CGI-I, 
PTQ, CPTR, 
TAQ 
 
13 ••• 
 
Rowe et al., 
2013 
 
 
 
12 
 
   70% 
   
33% 
   
23% 
 
17% 
• 
(CBIT) 
 
N/A 
 
8 
 
COSA, 
SUDS, PTQ, 
TSHT 
 
9 • 
 
Storch et al., 
2012 
 
 
 
12 
   
75% 
 
 
   N/A 
 
 
   N/A 
 
38% 
• 
(LWT) 
 
N/A 
 
10 
YGTSS, 
CGI-S, CGI-
I, Direct 
observation, 
CBCL, 
CTIM-P, 
MASC, 
PHSCS, 
PedsQL 
 
9 • 
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Study N Mean 
age 
% male % with 
OCD 
% with 
ADHD 
% on tic 
medication 
Treatment Control 
group 
No. of 
sessions 
Outcome 
measures 
Critical 
appraisal 
score 
Critical 
appraisal 
rating 
             
 
Verdellen et 
al., 2004 
 
 
 
21 
 
   
79% 
 
  
14% 
 
   
30% 
 
40% 
• 
(ERP) 
 
HRT 
 
ERP = 
12, 
HRT = 10 
 
YGTSS, TF-
institute, TF-
home 
 
14 ••• 
 
Wilhelm et al., 
2003 
 
 
 
 
35 
 
     
  55% 
 
 
  N/A 
 
 
  N/A 
 
 
48% 
• 
(HRT) 
 
Supportive 
psycho-
therapy 
 
 
 
14 
 
YGTSS, 
CGI-I 
 
12 •• 
 
Wilhelm et al., 
2012 
 
 
 
32 
 
     64% 
  
18% 
   
28% 25% 
• 
(CBIT) 
 
Supportive 
treatment 
 
8 
 
YGTSS, 
CGI-I, ATQ 
 
15 ••• 
Note. Gender: ∎ = male, ∎ = female 
OCD comorbidity: ∎ = comorbid diagnosis, ∎ = no comorbid diagnosis 
ADHD comorbidity: ∎ = comorbid diagnosis, ∎  = no comorbid diagnosis 
Tic medication: ∎= taking tic medication, ∎ = not taking tic medication 
N/A = Not Available or Not Applicable 
Treatment: • = BT, • = BT using novel treatment delivery method, • = CBT, •= third wave CBT 
Population sample:  = Demographic data available for recruited sample,  =Demographic data available for analysed sample 
YGTSS = Yale Global Tic Severity Scale, CGI-I = Clinical Global Impression – Improvement scale, SDI = Sheehan disability inventory, SOS-10 = Schwartz 
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Outcome Scale, VSP = visuospatial priming, WSAS = Work and Social Adjustment Scale, CGI-S = Clinical Global Impression – Severity Scale, PTQ = Parent Tic 
Questionnaire, WAI = Working Alliance Inventory, TAQ = Treatment Acceptability Questionnaire, CTIM-P = Child Tourette's Syndrome Impairment Scale, PedsQL = Pediatric 
Quality of Life Inventory-Child Version, CY-BOCS = Children's Yale–Brown Obsessive Compulsive Scale, MASC = Multidimensional Anxiety Scale for Children, TSGS = 
Tourette Syndrome Global Scale, BDI = Beck Depression Inventory, BAI = Beck Anxiety Inventory, VOCI = The Vancouver Obsessional Compulsive Inventory, BIS-11 = Barratt 
Impulsiveness Scale, PUTS = Premonitory Urge for Tics Scale, SUDS = Subjective Units of Discomfort, SSI = Social Self-esteem Inventory, LES = Life Experience Survey, 
STAI = Speilberger State-trait Anxiety Inventory, GHQ = General Health Questionnaire, MOCI = Maudsley Obsessional–Compulsive Inventory, EPI = Eysenck Personality 
Inventory, CGAS = Children’s Global Assessment Scale, ATQ = Adult Tic Questionnaire, FFMQ = Five Facet Mindfulness Questionna ire, KBIT = Kaufman Brief Intelligence 
Test, MINI-Kid = Mini International Neuropsychiatric Interview – Kid, WASI = Wechsler Abbreviated Scale of Intelligence, CPTR = Children’s Perception of Therapeutic 
Relationship, COSA = Child Occupational Self-Assessment, TSHT = Tic Symptom Hierarchy Tracker, CBCL = Child Behavior Checklist, PHSCS = Piers-Harris Children's Self-
Concept Scale, TF-institute = tic frequency observed at the institute, TF-home = tic frequency monitored at home 
Critical appraisal: ••• = scoring ≥ 13, •• = scoring 10 – 12, • = scoring ≤ 9 
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3.3 CRITICAL APPRAISAL 
Critical appraisal scores ranged between 9 and 15 with a median score of 11.5. 
Wilhelm et al. (2012) and McGuire et al. (2015) achieved the highest scores of 15. 
Articles scoring below 8 were not included in this review. 
3.3.1 Methodological factors 
Reporting of demographic data and inclusion/exclusion criteria 
Tourette syndrome is a heterogeneous disorder in which the severity of symptoms is 
partially influenced by patient demographics such as age and gender. TS has a 
higher prevalence amongst males with a typical ratio of 4:1 (Robertson, 2008) and 
tends to peak in severity in early adolescence, with research describing a ‘bell-
shaped’ severity curve. Tic severity may also be influenced by stress factors, 
comorbid conditions, and medication status. Clear reporting of sample demographic 
data is therefore integral to the accurate interpretation of any study findings. The 
majority of studies included in this review (N=12) presented clear demographic data 
with mean values and measures of variance. The remaining studies presented 
partial data, typically omitting information on comorbidity and/or medication. All 
studies (N=16) reported inclusion and exclusion criteria, which typically included 
diagnosis, age, symptom severity, medical and treatment history, and IQ. 
Description of the intervention 
All 16 studies were deemed to have offered a comprehensive description of the 
treatment protocol used, including a description of the treatment components, total 
number of sessions and therapist qualifications.  
Use of a control group 
Ten studies used a control group which consisted of either a supportive 
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psychotherapy intervention (N=4), an alternative tic intervention (N=1), a waitlist 
group (N=3) or a treatment controlling for one aspect of the trialed intervention such 
as Himle et al.’s (2012) study which investigated the effect of treatment modality 
whilst controlling for type of treatment (CBIT) or Franklin et al.’s (2011) study which 
investigated the additive effect of ACT treatment components to an HRT 
intervention. 
Eight controlled studies reported using a random allocation process to assign 
participants to groups, with four of these studies reporting stratification by 
medication status and one study also stratifying by gender (Ricketts et al., 2015b). 
Pre-randomisation stratification can be considered a useful technique for smaller 
sample sizes as a way of avoiding chance imbalances in baseline characteristics 
that randomisation can sometimes create (Schulz & Grimes, 2002). Franklin et al. 
(2011) allocated participants to groups by consecutive referral whilst O’Connor et 
al.’s (2001) study used partial randomisation with every third participant randomised. 
Almost all the controlled studies reported testing for significant differences between 
the baseline characteristics of each group, with the exception of Franklin et al. 
(2011) who do not make reference to this process. 
Validity of tic severity outcome measures 
Fourteen studies used the Yale Global Tic Severity Scale (YGTSS) as the primary 
outcome measure. The YGTSS is a gold standard clinician-rated measure of tic 
severity with good validity as well as good interrater reliability (Leckman et al., 1989; 
Walkup, Rosenberg, Brown & Singer, 1992, cited in Deckersbach et al., 2006). In 
place of the YGTSS, Rowe et al. (2013) used the PTQ, TSHT and SUDS and 
O’Connor et al. (2001) asked participants to complete a daily tic diary with measures 
of tic frequency, intensity and subjective degree of control over tics, as well as using 
video recording for direct observation.
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Intervention • • • • • • • • • • • • • • • • 
 
Demographic 
data 
• • • • • • • • • • • • • • • • 
 
Inclusion/ 
exclusion 
criteria 
• • • • • • • • • • • • • • • • 
 
Participant 
recruitment 
• • • • • • • • • • • • • • • • 
 
Control 
condition 
• • • • • • •a • • • • • • • • • 
 
Independent 
evaluators 
 
• • • • • • • • • • • • • • • • 
Validity of 
outcome  
measures 
 
• • • • • • • • • • • • • • • • 
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Consideration 
of sample size 
and statistical 
power 
• • • • • • • • • • • • • • • • 
 
Reporting of 
statistics 
• • • • • • • • • • • • • • • • 
 
Estimates of 
random 
variability 
• • • • • • • • • • • • • • • • 
 
Correction for 
multiple 
comparisons 
• • • • • • • • • • • • • • • • 
 
Statistical 
analysis of 
baseline group 
differences 
• • • • • • • • • • • • • • • • 
 
 
Confounding 
factors 
• • • • • • • • • 
 
• • • • • • • 
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Note. Intervention: • = not described, • = partially described, • = fully described 
Demographic data: • = not reported, • = partially reported, • = fully reported 
Inclusion/exclusion criteria: • = not reported, • = reported 
Participant recruitment: • = process not described, • = process described, • = process described and representative sample obtained 
Control condition: • = no control group, • = use of control group, • = use of control group with participant randomisation 
Independent evaluators: • = evaluators not independent or difficult to determine, • = independent evaluators 
Validity of outcome measures: • = outcome measures lack validity, • = valid/gold standard outcome measures used 
Consideration of sample size and power: • = not considered, •= considered 
Reporting of statistics: • = unclear reporting, • = clear reporting 
Estimates of random variability: • = not reported, • = reported 
Correction for multiple statistical comparisons: • = statistical corrections not reported, • = statistical corrections reported 
Statistical analysis of baseline group differences: • = not carried out, • = reported 
Confounding factors: • = not statistically considered and accounted for, • = statistically considered and accounted for 
a This study used partial randomisation with every third participant randomised. This information was omitted from the publication of the study and obtained through personal 
correspondence with the author. 
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3.3.2 Statistical factors 
Consideration of sample size and power analysis 
Four studies reported considerations of power and sample size. Wilhelm et al. 
(2012) and Piacentini et al. (2010) considered attrition rate (estimated at 10%), 
significance level (0.05), power (80%) and an estimate of effect size (0.55) to justify 
their sample sizes. Franklin et al. (2011) acknowledge that their study was “not 
powered to conduct traditional significance testing” and present their study as a 
feasibility report, based on findings from an exploratory analysis. Storch et al. (2012) 
acknowledged that due to their small sample size, reported effect sizes would be of 
more worth than the reported p values. Sample sizes ranged from seven (Nonaka et 
al., 2015) to 126 (Piacentini et al., 2010). 
 
Reporting of statistical results 
Most of the studies presented clear results of statistical analyses and reported mean 
scores and measures of random variability. Twelve studies reported effect sizes, 
with the majority using Cohen’s d (N=7) or Partial Eta Squared (N=2), whilst Ricketts 
et al. (2015a) reported r values from a Wilcoxon Signed-Rank test. Piacentini et al. 
and Wilhelm et al. (2012) also provide specific descriptions of their effect size 
calculations. 
Verdellen et al. (2004) also include a measure of ‘percentage of patients who 
improved’ (PPI) in each treatment group, based on a 30% improvement on the 
YGTSS, whilst Nonaka et al. (2015) report the number of patients who 
demonstrated 25% YGTSS improvement. These percentages are in line with 
research that suggests a 25% improvement on the YGTSS would reflect a clinically 
meaningful change (Jeon et al., 2013). 
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Multiple statistical comparisons 
Wilhelm et al. (2012) acknowledge that no adjustments were made for multiple 
comparisons when testing secondary outcomes, whereas no other studies comment 
on the need for, or use of, such corrections. 
3.3.3 Confounding factors 
Most studies considered medication status, baseline tic severity and/or comorbidity 
as potential confounding variables and used preemptive or post-hoc methods to 
either reduce the impact of these or statistically control for them. All control group 
studies used a statistical approach to test for significant baseline differences 
between groups, with the exception of Franklin et al. (2011) who did not make 
reference to this approach. As previously mentioned, five control group studies also 
used a stratified allocation process to ‘match’ participants on baseline 
characteristics. 
Six studies conducted post hoc statistical analyses to measure for any potential 
influence on outcomes from confounding variables by either incorporating these 
factors as covariates in the initial or secondary analyses or performing a statistical 
adjustment. Deckersbach et al. repeated their analysis including baseline 
medication status and comorbidity as covariates, whilst Wilhelm et al. (2003) 
included baseline measures of tic severity and impairment as covariates. Wilhelm et 
al. (2012) and Piacentini et al. report that neither medication status nor baseline tic 
severity moderated treatment outcome on the YGTSS. 
Piacentini et al. and Himle et al.’s studies were conducted across multiple sites and 
both therefore included ‘site of treatment’ as a variable in the initial analyses with 
neither finding any significant differences in treatment outcome across sites. 
Verdellen et al. compared eight sessions of HRT to 10 sessions of ERP and 
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adjusted for the unequal number of treatment sessions in the statistical analysis by 
obtaining weighted gain scores. 
Six studies conducted an ‘intention to treat’ analysis to control for a potential dropout 
effect (Deckersbach et al., 2006; McGuire et al., 2015; Piacentini at al., 2010; 
Ricketts et al., 2015b; Verdellen et al., 2004; Wilhelm et al., 2012). Eight studies 
conducted analysis on completers only, and three studies reported no dropouts 
(Franklin et al., 2011; Rowe et al., 2013; Storch et al., 2012). 
3.4 OUTCOMES 
3.4.1 Behavioural treatment 
Six studies investigated the efficacy of behavioral treatment for TS. Wilhelm et al. 
(2012), Piacentini et al. (2010) and Nonaka et al (2015) examined the efficacy of 
CBIT, Deckersbach et al. (2006) and Wilhelm et al. (2003) examined the efficacy of 
an HRT intervention, whilst Verdellen et al. (2004) compared treatment response to 
HRT versus ERP. 
Habit Reversal Training 
Most of the studies in this review investigated the efficacy of behavioural treatment 
for TS. The earliest of these studies being an RCT conducted by Wilhelm et al. 
(2003) that investigated the efficacy of HRT for TS by randomly assigning 32 adult 
participants to either 14 sessions of HRT or supportive psychotherapy. Outcome 
was measured using the YGTSS and analysis found that at post-treatment and at 
10-month follow-up, HRT patients had significantly lower tic severity and functional 
impairment scores compared to the comparison group. This effect was maintained 
when statistically controlling for baseline severity and impairment. The authors 
concluded that habit reversal training should be considered an effective behavioural 
treatment for TS. 
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This study benefits from the use of a comparison group that controlled for non-
treatment related effects such as therapist contact. It does however also have 
limitations. Participants were recruited in part through newspaper advertisements, 
an opportunity sampling method that carries a self-selecting bias and therefore may 
not be wholly representative of the general TS population. Although a gold standard 
tic severity measure was used, raters were not blind to group allocation, leaving the 
outcome measure vulnerable to bias from rater expectations. Nevertheless, this 
study paved the way for larger studies to follow suit and address some of these key 
validity issues. 
Deckersbach et al. (2006) were able to replicate much of Wilhem et al.’s 
methodology with a sample of 30 adult participants. This RCT compared the efficacy 
of HRT and supportive psychotherapy on tic severity, life satisfaction and 
psychosocial functioning. Furthermore, participants were asked to complete a pre-
treatment visuo-spatial priming task to measure behavioural response inhibition, in 
order to investigate whether baseline response inhibition would be a predictor of 
treatment response. Outcome measures included the YGTSS and CGI-I as 
measures of clinical change, as well as the Sheehan disability inventory (Leon et al., 
1992, cited in Deckersbach et al., 2006) which measured psychosocial functioning 
and the Schwartz Outcome Scale (SOS-10; Blais et al., 1999, cited in Deckersbach 
et al., 2006) which measured life satisfaction. Results indicated that the HRT group 
demonstrated significantly lower levels of tic severity mid-treatment (8 weeks) and 
post-treatment when compared to the control group. These outcomes were 
maintained when controlling for baseline tic severity, comorbidity and medication. 
This suggests that a shorter treatment protocol of eight sessions may be just as 
effective as a longer course of treatment. Both groups showed improvement on 
psychosocial functioning and life satisfaction measures, highlighting the potential 
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benefits of supportive psychotherapy as a treatment approach for TS where HRT 
may not be available. Patients demonstrating greater inhibitory priming at pre-
treatment showed greater tic severity improvements following HRT, suggesting that 
inhibitory processes may mediate treatment response.  
This study would benefit from a larger sample and similar to the study by Wilhelm et 
al., did not use rater-blinded outcome measures leaving it at risk of rater-bias. 
Exposure and Response Prevention 
Verdellen et al. (2004) compared the efficacy of two behavioural treatments: HRT 
and ERP. They conducted an RCT with 43 TS patients allocated to either 10 
sessions of HRT or 12 sessions of ERP. A cross-over design was used meaning 
that after treatment completion, participants were offered the alternative approach 
as an additional treatment and findings from this second phase of the study were 
analysed separately to assess for any additional treatment benefits. The impact of 
treatment on tic severity was measured by the YGTSS and a tic frequency count 
during an observation of a 15 minute videotaped session in the clinic, as well as a tic 
frequency count by a family member during a 15 minute direct observation at home. 
Unlike the previously mentioned studies, assessors were blind to treatment 
allocation. 
Multivariate analysis showed that both treatment groups significantly improved on 
measures of tic severity and there were no significant differences between 
treatments suggesting that both ERP and HRT are good behavioural treatment 
options for TS. 
The second phase of the study showed additional improvement in patients receiving 
ERP following HRT, but no additional improvement in patients receiving HRT 
following ERP suggesting that ERP may offer supplementary therapeutic benefits. 
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Tic frequency measures were weakly related (r = 0.25) suggesting low reliability of 
one or more measures. Video and direct observation can be limited by the impact of 
context-specific tics and although the comparison group will have controlled for this 
variable to some extent, context-specific observational assessments may still 
inevitably prove less reliable than standardised measures of tic severity. 
Although Verdellen et al. controlled for unequal treatment lengths (10 versus 12 
sessions) through the use of weighted gain scores, no statistical adjustment was 
applied to account for unequal session duration times. Descriptions of treatment 
protocols in this article mention that each ERP session lasted 120 minutes, whilst 
HRT sessions are described as lasting 60 minutes meaning that even when 
controlling for number of treatment sessions, participants in the ERP group would 
have received twice as much patient-therapist contact time compared to the HRT 
group. 
 
Comprehensive Behavioural Intervention for Tics 
The largest RCT included in this review was conducted by Piacentini et al. (2010). 
It investigated the efficacy of an eight session Comprehensive Behavioural 
Intervention for Tics (CBIT) compared to a control group offering supportive 
psychotherapy and education. Clinical outcomes were measured using the YGTSS 
and CGI-I in a sample of 126 children. 
Following 10 weeks of treatment, scores on the YGTSS improved significantly more 
in the CBIT group compared to the supportive psychotherapy group, with a group 
difference effect size of 0.68, whilst the CGI-I recorded a significantly larger 
percentage (52.5%) of ‘improvers’ (those rated as ‘very much improved’ or ‘much 
improved’) compared to the control group (18.5%), suggesting a clinically 
meaningful improvement for participants completing the CBIT treatment. Woods et 
42 
 
al. (2011) conducted a further analysis on the same sample, examining the effects 
of CBIT on secondary psychiatric symptoms as well as psychosocial symptoms. 
Results found that positive response to treatment at 10 weeks was also associated 
with an improvement in secondary psychiatric and psychosocial symptoms at 6-
month follow-up, highlighting the potential added benefits of CBIT. 
This was a large sample study with good demonstrable power, low attrition rate and 
independent, blinded raters. Interventions were matched for treatment duration and 
length and potential confounds such as medication status and baseline tic severity 
were considered in the analysis.  
Wilhelm et al. (2012) conducted a similarly large RCT with 122 adult participants 
comparing the efficacy of eight sessions of CBIT to an eight session control group 
offering ‘supportive treatment’. 
Results found CBIT to be more effective at reducing symptoms on the YGTSS than 
the control condition. The analysis also found a significantly greater proportion of 
improvers as measured by the CGI-I in the CBIT group compared to the control 
condition. The analysis controlled for possible site effects as well as baseline tic 
severity and medication status. 
It is worth noting that the authors report on six participants who scored above 30 on 
the severity ratings of the YGTSS at baseline (the inclusion threshold for the study). 
This score indicates a very high level of severity in these participants.  It is stated 
that three of the six participants were then accepted onto the trial following a panel 
review. The reason for this is not elaborated on in the article suggesting a possibility 
of bias as a result of pseudo-systematic selection methods. 
A comparison between the two largest CBIT studies, Piacentini et al. and Wilhelm et 
al. (2012) suggests that CBIT may be more effective for children than adults, with 
Piacentini et al. demonstrating comparatively larger effect sizes on both the YGTSS 
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and CGI-I with a similar methodology and sample size. 
Nonaka et al. (2015) present a small, yet important, study that evaluates the 
feasibility of a CBIT intervention in a non-Western population. Seven Japanese 
subjects were offered nine sessions of CBIT and evaluated both pre- and post-
intervention to assess for treatment effects. TS symptoms were measured using the 
YGTSS, PUTS and a subjective units of distress scale (SUDS). Analysis showed a 
significant improvement on the YGTSS and SUDS, but not on the PUTS suggesting 
that subjects may continue to experience a similar level of premonitory urges 
despite an overall reduction in tic expression and distress. 
It is worth noting that one participant dropped out of the study after the third 
treatment session due to finding it too difficult to talk about their tics. This participant 
was not included in the analysis and therefore the possibility of a dropout effect 
should be considered. 
As this is a small study with no control group, it is difficult to determine how much of 
the change seen in these measures can be attributed to treatment effects. TS 
symptoms typically fluctuate over time (Robertson, 2008) and natural recovery is 
common, particularly in adolescence. Without a control group, it is difficult to 
determine how much of the symptom change may be as a result of the natural 
waxing and waning of the symptoms. Despite these limitations, it is the only non-
Western study included in this review, and contributes evidence to the cross-cultural 
validity of CBIT. 
3.4.2 Cognitive behavioural treatment 
The majority of studies included in this review focus on behavioural treatment such 
as HRT and CBIT, however, there are also a number of studies that have based 
their trials on a cognitive behavioural treatment protocol. Four CBT studies have 
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been included in this review, implementing either the O’Connor et al. (2005) protocol 
(cited in Morand-Beaulieu et al., 2015) or the ‘Living with Tics’ protocol (a broad-
ranging CBT approach developed by Storch et al., 2012). These two tic treatment 
protocols are comparable as they both augment traditional behavioural techniques 
with cognitive restructuring components. 
‘Living With Tics’ 
Storch et al. (2012) reported on a sequential case series of eight youth that 
underwent CBT treatment for tics using the ‘Living with Tics’ (LWT) protocol. The 
LWT protocol consists of modules that include psychoeducation and cognitive 
restructuring targeting distorted beliefs. The focus of this approach is to improve 
quality of life rather than directly reduce tic severity, however an introduction to HRT 
strategies is also included with the aim of contributing to the individual’s self-
efficacy. This is a needs-assessed modular intervention in which the choice of 
modules and time devoted to each module is tailored to the individual needs of the 
child. 
Tic severity was measured pre- and post-treatment using the YGTSS, the Clinical 
Global Impression-Severity (CGI-S) scale and via direct observation. In addition to 
this, changes over time in child behavior, impairment, self-concept, anxiety and 
quality of life were measured. Significant improvements were seen on the CGI-
severity scale as well as the impairment subscale of the YGTSS, but not on the 
overall YGTSS total score, suggesting improvement in impairment but not in overall 
tic severity. No significant change was recorded from direct observation. 
Furthermore, the study found significant improvement in anxiety, self-concept and 
quality of life following treatment completion. 
This study suggests that augmenting traditional behavioural treatment with cognitive 
components can help to address emotional and cognitive symptoms associated with 
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TS that may not be directly addressed by traditional behavioural treatment. 
This was a small case series designed to investigate the feasibility and acceptability 
of the LWT protocol: a new CBT protocol for tics. Due to the small sample size, 
there are limitations to the extent that statistical significance testing could accurately 
measure change over time. Raters were not blinded and the study was susceptible 
to the vulnerabilities typical of uncontrolled treatment testing. Limitations of this 
study were addressed in a larger trial of LWT by McGuire et al. (2015). 
McGuire et al.’s study evaluated the efficacy of the LWT protocol relative to a waitlist 
control group with a sample of 24 children and adolescents. Similar outcome 
measures were used as in Storch et al.’s study with the addition of the Children’s 
Yale-Brown Obsessive Compulsive Scale (CY-BOCS). 
Significant improvement was demonstrated on the YGTSS impairment scale and 
quality of life scale, as demonstrated in Storch et al.’s findings. No significant 
change was seen on the YGTSS total tic score or anxiety scale. Furthermore, after 
the waitlist participants were offered LWT treatment, an open-trial analysis was 
conducted on a larger sample of 19 subjects which found significant improvement 
on all measures following treatment, suggesting that previous analyses may have 
been under-powered to find smaller effects of treatment. 
The use of a non-active control group leaves this study vulnerable to bias as it would 
be difficult to control for any clinical change attributable to non-specific therapeutic 
components and use of an active control could be an important future adaptation to 
this study. It is also important to acknowledge that only waitlist participants classed 
as ‘completers’ (N= 10/12) were later offered the active treatment and only 7 out of 
these 10 participants accepted and undertook this treatment and hence were 
included in the open-trial analysis. Using completers only increases the risk of a 
dropout effect and reasons for why the other three participants declined participation 
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at this stage were not provided. This leaves the potential for a self-selecting bias in 
the open-trial analysis, suggesting that results should be interpreted with caution. 
This is, however, the first modular intervention for children with TS which reports a 
potentially effective, broad ranging treatment which also takes into account co-
occurring conditions. 
One of the earliest trials, conducted by O’Connor et al. (2001), looked at the 
effectiveness of a CBT treatment program for individuals with chronic tic disorders 
(CTD) and habit disorders (HD). Forty-four adult participants diagnosed with chronic 
tic disorder completed a daily tic diary recording frequency, intensity and self-
perceived ability to control tics at pre- and post-treatment. Fourteen of these 
participants were placed in a waitlist control group to control for the natural 
fluctuations in tic severity. Video observations were also recorded and 
independently-rated. 
Following a 12-session treatment programme, the intervention group demonstrated 
a significantly greater decrease in tic frequency and intensity and an increase in self-
perceived degree of control compared to the control group. There was also a 
significant decrease in symptoms on accompanying questionnaires in the CBT 
condition including the Beck Depressive Inventory (BDI), the General Health 
Questionnaire (GHQ), and the Speilberger State-trait anxiety Inventory (STAI). A 
significant increase in self-esteem was also reported on the Social Self-esteem 
Inventory (SSI). 
This study was one of the first controlled trials to investigate the efficacy of CBT as a 
tic treatment. Although it used a waitlist control group as part of the experimental 
design, baseline group differences between the intervention and waitlist group were 
not tested for, making it difficult to attribute any changes observed in the treatment 
condition to the intervention rather than pre-existing group differences. O’Connor et 
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al. also note the initial exclusion of subjects with ‘severe’ or ‘extreme’ TS and/or 
comorbid psychiatric conditions. Most studies in this review have included 
participants with comorbidities such as OCD or ADHD given the high prevalence of 
these co-occurring with TS. This exclusion makes findings from O’Connor et al.’s 
study less generalisable to the TS population. 
Morand-Beaulieu et al. (2015) observed the effect of CBT on tic severity, inhibition 
and motor activation in a pre-post design. A stimulus-response compatibility 
inhibition task was used to measure change in inhibition, whilst electrophysiological 
recordings, such as event related potentials (ERPs), measured motor cortical 
activation. Tic severity was measured by the YGTSS and TSGS. 
Twenty adult patients attended a 14-session course of CBT that included traditional 
components of HRT as well as elements of cognitive restructuring practiced in ‘high 
tic-risk situations’. Results found that tic symptoms, as measured by the YGTSS and 
TSGS, significantly improved following CBT whilst CBT also appeared to have a 
normalising effect on cortical motor activation. There was no significant change in 
inhibitory function. 
It should be noted that this study had a high dropout rate (30%), which may in part 
have been due to the large amount of testing involved as part of the assessment 
procedure or the lengthy treatment protocol. The likelihood of a drop out effect may 
therefore need to be considered when evaluating findings.  
The authors also highlight the impact of having a wide age range of participants 
when measuring certain ERPs that would be dependent on brain maturation and 
therefore, developmental stage. Despite the limitations, these findings contribute 
evidence to the range of benefits associated with CBT treatment for tics and 
highlight the need for research to further explore potential neuropsychological 
treatment outcomes. 
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3.4.3 Third wave cognitive behavioural treatment 
Two studies investigated the efficacy of third wave CBT approaches, augmenting 
standard protocols with components of ACT (Franklin et al., 2011) and mindfulness-
based stress reduction (Reese et al., 2015). 
Franklin et al. (2011) piloted an HRT protocol combined with components of ACT 
(HRT+ACT) and compared against an HRT-only control. Thirteen adolescents and 
young adults received either 10 sessions of HRT or 12 sessions of HRT+ACT. 
Tic severity was measured using the YGTSS and findings suggest that both groups 
demonstrated significant improvement in tic symptoms over time, but found no 
significant difference between the two interventions. CGI-I scores did however 
indicate that the HRT condition may have been slightly more effective than the 
HRT+ACT condition, indicating that ACT components may not have necessarily 
provided additional therapeutic benefits. 
It is important to consider these results in the context of the study’s limitations. 
Firstly, as is the case for most feasibility studies, this study was underpowered. 
Secondly, the two treatment groups did not have an equal amount of treatment 
sessions and this disparity does not appear to be addressed in the statistical 
analysis, making direct comparison between interventions difficult. Thirdly, the study 
mentions using five different therapists to administer treatment, one of which had 
significantly more experience in ACT than the others. The authors considered 
expertise as a potential confound and conducted a post-hoc comparison between 
YGTSS scores achieved by the ‘beginner’ versus ‘intermediate’ ACT therapists. This 
comparison was depicted visually on line graphs and based on a visual inspection of 
the line graph the authors note that there appears to be a difference in clinical 
change achieved by the beginner versus intermediate therapists, in favour of the 
latter. This suggests the importance of controlling for therapist expertise in any 
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future studies in this area. The authors also note that potential moderators such as 
psychiatric comorbidity were not considered in the analysis due to a lack of 
statistical power. 
Reese et al. (2015) investigated the efficacy of a Mindfulness-Based Stress 
Reduction intervention for tics (MBSR-tics). Eighteen subjects were offered eight 
treatment sessions and a 4 hour retreat as part of an uncontrolled open trial. 
Treatment outcomes were measured using the YGTSS, CGI-I, adult tic 
questionnaire (ATQ), the work and social adjustment scale (WSAS) as well as the 
Five Facet Mindfulness Questionnaire (FFMQ) to measure change in self-reported 
mindfulness. 
Results show significant symptom reduction on the YGTSS tic severity score 
(d=1.03) and tic-related impairment (d=1.17) with treatment gains maintained at 1-
month follow-up. These clinical changes accompany significant increases in self-
reported mindfulness as measured by the FFMQ, and further analysis demonstrates 
how increases on the FFMQ were positively predictive of clinical change on the 
YGTSS (r=0.57, p=0.018). 
The authors acknowledge the need for blind assessment as well as a valid control 
condition to test whether clinical change is in fact attributable to mindfulness skill 
acquisition specifically and not just a result of the relatively large amount of therapy 
hours offered (20 hours). Despite the large amount of sessions, this is a relatively 
cost effective intervention given the group format and provides general support for 
the future use of group-based tic treatment. 
3.4.4 Novel treatment delivery modalities 
Four studies addressed the issue of limited treatment availability by piloting novel 
treatment delivery methods. All four studies adapted the standard CBIT protocol. Of 
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these four studies, two investigated the feasibility of using communication 
technology to deliver behavioural treatment remotely.  Ricketts et al. (2015) tested 
preliminary efficacy and feasibility of a voice-over internet protocol, whilst Himle et al 
(2012) observed response to a behavioural treatment delivered via videoconference 
technology. 
A further two studies addressed the accessibility issue by piloting the delivery of 
behavioural treatment by health professionals other than psychologists. Ricketts et 
al. (2015) observed treatment response to an abbreviated version of the CBIT 
protocol administered by nurse practitioners in developmental paediatrics and 
neurology clinics, whilst Rowe et al. (2013) observed response to a CBIT protocol 
administered by trained occupational therapists. 
Treatment delivery within novel clinical settings 
To increase the availability of behavioural treatment for the TS population, recent 
studies have tested the feasibility of non-psychology health professionals delivering 
CBIT in outpatient clinics. As TS patients are often first referred to neurology and 
paediatric clinics for assessment and consultation regarding their tic symptoms, 
Ricketts et al. (2015a) conducted a study evaluating the acceptability of an 
abbreviated CBIT protocol (CBIT-NP) delivered by either a nurse practitioner or 
physician with specialist neurology and/or developmental paediatric expertise. 
Nine youth completed six sessions of CBIT-NP each lasting 20-25 minutes. 
Measures of tic severity including the YGTSS and CGI-S were taken pre- and post- 
treatment. Results identified a significant reduction on the YGTSS total tic score and 
impairment score as well as a significant reduction in global impairment as 
measured by the CGI-S, with 56% of the sample classified as treatment responders. 
This study highlights the potential efficacy of a relatively short course of behavioural 
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treatment for tics. Due to the limited time available in each session, a greater 
emphasis was placed on homework tasks to be completed in between sessions. As 
a result, homework non-adherence may pose a significant barrier to the 
effectiveness of CBIT-NP. 
It is important to note that the study was uncontrolled and the sample size was 
small. Furthermore, evaluators were not blinded to pre- or post-treatment conditions 
and were aware of the study’s hypotheses. The study suffered a 36% attrition rate 
which raises questions about the acceptability of this treatment despite good 
satisfaction ratings reported by treatment completers. Addressing these issues could 
help refine a protocol that not only increases treatment availability but due to its 
clinical setting, may also help patients receive appropriate treatment sooner. 
Similarly to Ricketts et al., Rowe et al. (2013) explored the delivery of behavioural 
treatment by non-psychology practitioners, piloting an eight session CBIT protocol 
delivered by an occupational therapist. Thirty children took part in this study and 
were evaluated pre- and post-treatment using the PTQ, SUDS and the Tic Symptom 
Hierarchy Tracker (TSHT) which all measured tic severity, as well as the Child 
Occupational Self-Assessment (COSA) which measured changes in occupational 
performance. Following treatment, a significant reduction in scores on the PTQ and 
SUDS was observed as well as a significant improvement in self-perceived 
occupational performance. 
This study did not benefit from a control condition, making it difficult to determine the 
specific effect of the intervention above and beyond generic therapeutic effects such 
as those garnered from therapist-contact. Additionally, it is important to note that tic 
outcomes were not independently rated, making them vulnerable to experimenter 
bias. The authors also question the validity of the COSA as a measure of 
occupational performance in patients with tic disorders as it was not originally 
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designed to be used for this purpose. 
Nonetheless, these findings support the feasibility of non-psychologist health 
professionals, such as occupational therapists, administering CBIT. This treatment 
approach demonstrates the potential and opportunity for experts with different 
training backgrounds to transfer their skills and contribute to the delivery of TS 
interventions. In this example, occupational therapists could use their knowledge of 
functional performance to expand the focus of behavioural tic treatment to 
secondary outcomes such as improved general functioning and quality of life 
outcomes in addition to focusing on tic symptom improvement. 
 
Remote treatment delivery using communication technology 
To further address the limited availability of behavioural treatment for tics, studies 
have evaluated the efficacy of novel treatment delivery modalities to help increase 
therapy provision. Himle et al. (2012) explored the effectiveness of CBIT delivered 
via videoconference technology by recruiting twenty children to a randomised 
controlled pilot trial comparing videoconference delivery to traditional face to face 
CBIT. 
Clinical change was measured using the YGTSS, CGI-I and Parent Tic 
Questionnaire (PTQ). The analysis took into consideration ‘site’ as a variable in this 
multi-site trial as well as condition and time. Results identified a significant 
improvement in tic symptoms for both conditions on both the clinician-rated YGTSS 
and parent-rated measure, with no significant difference between the two delivery 
modalities and no effect of site. Whilst the sample size is small, these results 
provide some evidence for the comparable efficacy of videoconference CBIT and 
face to face CBIT, and present a promising treatment alternative that can help 
overcome geographical barriers to treatment provision. Crucially, children and adults 
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found both forms of delivery acceptable and there were no significant differences on 
working alliance scales as one might predict when comparing a face to face contact 
to telehealth. 
Building on these findings, Ricketts et al. (2015b) investigated the efficacy of voice 
over internet protocol-delivered CBIT (CBIT-VoIP), a telehealth delivery modality 
that can be set up at a patient’s home using an ordinary computer, internet 
connection and web camera. Twenty youth were randomised to either CBIT-VoIP or 
a waitlist control. The CBIT-VoIP group received CBIT delivered by a Master’s level 
trained therapist via Skype software. 
Outcomes were measured using the YGTSS and PTQ. The CBIT-VoIP group 
demonstrated a significantly greater improvement in tic severity over time (28.2%) 
compared to the control group. This is a similar tic severity reduction to that 
observed in the original VOIP trial (33%; Himle et al., 2012)  and in a large study of 
face to face CBIT (30.8%; Piacentini et al., 2010). Differences between the 
intervention and control group on impairment score change, however, did not meet 
significance, in contrast to the original VOIP trial (Himle et al., 2012) where a 
significant reduction in impairment was observed. The authors hypothesised that 
this may have been due to a delayed therapeutic influence on psychosocial 
functioning. 
Results found a significantly larger proportion of CGI-I treatment ‘responders’ in the 
CBIT-VoIP condition relative to the control, however the proportion of responders in 
the CBIT-VoIP condition (33%) was still significantly lower than both the original 
VOIP trial (80%; Himle et al., 2012) and the large face to face CBIT trial (52.5%; 
Piacentini et al. 2010). This may have been in part due to technical difficulties 
recorded in a large proportion (37.6%) of CBIT-VoIP sessions. Future studies 
evaluating telehealth delivery of CBIT could benefit from implementing changes to 
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the internet protocol to reduce the likelihood of technological difficulties. 
Therapists also reported difficulties with child and parent focus and homework 
adherence in the intervention condition. These difficulties may have arisen as a 
result of this study being largely conducted from the subjects’ homes without 
specialist technology, unlike Himle et al (2012)’s study, which used a similar 
methodology within a university setting with specialist equipment. Rickett et al.’s 
methodology strengthens the ecological validity of this study and presents a 
treatment approach that can be easily implemented with the wider treatment-
seeking TS population. Adaptations to the protocol such as adding internet 
programs for homework completion and improving the sound and visual quality 
could contribute to better future treatment adherence and outcomes. This study 
could also benefit from an active control condition such as face-to-face CBIT, in 
order to enable a more specific measurement of the effect of treatment modality 
whilst controlling for therapeutic contact. 
 
3.4 SUMMARY 
This review draws together empirical support for established behavioural 
approaches with an emerging evidence base for new and adapted psychological 
interventions, evaluating the quality of the evidence base as a whole so that 
conclusions can be made for best practice. 
Literature findings from the systematic search illustrate a shift in experimental focus 
within the area of TS. Where older studies have focused on measuring the efficacy 
of traditional behavioural approaches such as HRT and ERP, more recent studies 
have focused on evaluating treatment outcomes for adapted and enhanced multi-
component approaches such as LWT (McGuire et al., 2015) and HRT+ACT 
(Franklin et al., 2011) that draw together multiple therapeutic tools, as well as novel 
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treatment delivery methods (Ricketts et al., 2015a), with the aim of improving both 
outcomes and treatment accessibility. This shift in empirical focus addresses some 
of the current challenges that behaviour therapy for tics faces, such as limited or 
partial patient therapeutic response and treatment availability (McGuire et al., 2015). 
Findings from this review highlight a discrepancy in the quality of research in 
psychological interventions for TS. Behavioural approaches such as HRT and CBIT 
appear to be supported by larger, more rigorous RCTs, whilst there is a noticeable 
lack of RCTs supporting the more recently developed third wave therapeutic 
approaches. Treatments such as mindfulness-based stress reduction for tics could 
benefit from controlled trials with larger samples. This in turn would enable direct 
comparisons to be made more confidently across the evidence base. The most 
rigorous of the studies included in this review are Piacentini et al. (2010) and 
Wilhelm et al. (2012), benefiting from large samples enabling well-powered designs 
with statistical consideration for potential confounds such as medication and 
baseline tic severity. These two studies reported similarly large effect sizes, 
demonstrating significant reductions in tics and tic-related impairment in individuals 
following behavioural treatment. Slightly larger effect sizes were observed in the 
child sample (Piacentini et al.) compared to the adult sample, producing results 
comparable to that of large placebo-controlled drugs trials of antipsychotic 
medication (Sallee et al., 2000). These findings support the use of behavioural 
therapy for TS and set a high quality standard for future research. 
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4. DISCUSSION 
 
4.1 CONCLUSIONS 
This review includes studies with a broad range of research quality investigating a 
variety of different therapeutic approaches. Despite this, positive outcomes still 
appear to be demonstrated across the range of treatments. These findings are 
supported by research studies that have explicitly compared two different treatment 
protocols (Franklin et al., 2011; Verdellen et al., 2004) and found comparable 
results. Studies evaluating traditional behavioural methods demonstrated the 
greatest treatment response overall, however these traditional approaches are also 
supported by more rigorous empirical research. Given that the body of high quality 
RCTs sits within traditional behavioural approaches, newer approaches will require 
high quality evaluation before conclusions about ‘a best approach’ can be made. 
 
4.2 METHODOLOGICAL ISSUES 
Conclusions made from this review should be considered in the context of the 
collective limitations of the studies included. Firstly, as mentioned previously, 
considerable sample size variation across studies was observed. Most of the studies 
included in this review described themselves as pilot or feasibility studies to reflect 
the relatively small sample sizes, which is naturally a limitation of the literature 
overall. Sample sizes ranged from 7 (Nonaka et al., 2015) to 126 (Piacentini et al., 
2010), indicating varying levels of study quality and suggesting that direct 
comparisons between studies should be made with caution.  
Secondly, it is important to acknowledge the lack of cross-cultural empirical 
evidence in this area of research, with most of the study samples included in this 
review representative of North American populations and only one of an Asian and 
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one of a European population. At present, there is no available data from studies in 
Africa. 
The review consisted of ten controlled trials and seven uncontrolled pilot studies. By 
including both controlled and single group studies, this review offers a broad 
reflection of the current literature available. Studies that do not have a control group 
do however present significant challenges when drawing comparative conclusions 
amongst patient populations that experience regular disease status fluctuation and 
natural recovery (Paulus et al., 2014). These challenges are relevant to TS 
populations for whom symptoms regularly wax and wane and for whom (natural or 
treatment-aided) recovery by the age of 18 is common. However, it can be argued 
that the potential for natural recovery diminishes with increasing disease duration (Ip 
et al., 2013) and therefore studies that exclude recently diagnosed participants may 
be less prone to the potential for natural recovery amongst participants during the 
treatment trial. Studies included in this review excluded participants exhibiting tic 
symptoms for a duration of less than one year, theoretically reducing the risk of 
natural recovery during the study and increasing the possibility of capturing a 
meaningful treatment effect (Ip et al., 2013). 
 
This review is broad-reaching of study methodology. Higgins and Green (2011) 
discuss the importance of undertaking, and therefore reporting on, non-randomised 
or uncontrolled trials, acknowledging that these studies evaluate initial feasibility that 
contributes to the development of future RCTs. These studies therefore hold an 
important functional purpose as part of the evidence base. Paulus et al. add that 
findings from pre-post design studies may also play a part in contextualising the 
findings of studies using alternative methodology. 
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4.3 CLINICAL IMPLICATIONS 
This review found positive results across a range of therapeutic approaches, 
suggesting that clinicians and patients may have some choice when deciding on the 
best course of psychological treatment for TS. However, it is important to consider 
that different protocols will place an emphasis on different treatment outcomes, with 
HRT focusing more heavily on direct improvement of tic symptoms and the LWT 
protocol placing an emphasis on quality of life outcomes and co-occurring conditions 
(e.g. anger, self-esteem, behaviour). It will therefore be important to determine the 
patient’s clinical needs and specific therapy goals before any final treatment 
decisions are made. 
Certain treatment protocols may also be more compatible to patients with comorbid 
disorders such as OCD or ADHD, offering transferable therapeutic skills. One 
example of this is ERP, a tic treatment that is also typically used to manage OCD 
symptoms (Abramowitz, 1996) and may prove a more intuitive treatment choice for 
individuals with comorbid TS and OCD. Comorbid ADHD on the other hand, has 
been found to be a significant moderator of behavioural treatment effect in 
individuals with TS (McGuire et al., 2014; Theule, Ward, Cheung & Lee, 2015), 
highlighting the importance of acknowledging individual factors such as patient 
comorbidity and treatment history when deciding upon a course of treatment. 
Further research into individual treatment mediating factors may improve successful 
treatment prescribing for patients.  
Evidence supporting newer treatment modalities such as telehealth (Himle et al., 
2012; Ricketts et al., 2015b) offers practical solutions to the issues of limited 
clinician availability. These approaches have also contributed to the development of 
further innovative treatment delivery solutions such as intensive outpatient 
programmes. 
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4.4 FUTURE RESEARCH 
Future research would benefit from a focus on high quality, well-powered studies 
that benefit from active controls, particularly when looking to replicate findings from 
some of the newer pilot studies emerging amongst the evidence base. As 
psychological treatments for TS continue to be developed, adapted and refined, and 
given the large variety of approaches demonstrating positive results, dismantling 
studies may help contribute to our understanding of the key active mechanisms of 
change within TS treatment. Recent meta-analytic data has considered the influence 
of separate therapeutic components (e.g. psychoeducation, relaxation training, 
contingency management) on psychosocial treatment efficacy. Theule et al. (2015) 
found a positive relationship between tic reduction and the inclusion of contingency 
management components, whilst interestingly, the inclusion of psychoeducation 
components corresponded to reduced treatment efficacy. The authors theorise that 
psychoeducation may take time away from the practice of tic management skills, 
leading to poorer outcomes. Future research would benefit from a further exploration 
of these ideas. 
A small body of emerging new research offers support for alternative approaches to 
cognitive behavioural therapies for TS such as exercise and music therapy. Packer-
Hopke (2014) found that a six-week aerobic exercise programme led to 
improvements in TS symptoms and quality of life in a small study of five TS 
participants, whilst a larger trial of 18 youth demonstrated an improvement in mood 
and anxiety levels as well as a reduction in tics during and post-exercise (Nixon, 
Glazebrook, Hollis & Jackson, 2014). Listening to music, live performance of music 
and musical mental imagery have all also been found to significantly reduce tic 
frequency (Bodeck, Lappe & Evers, 2015). Further research is needed to robustly 
explore the potential benefits of these novel approaches as well as the opportunity 
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for incorporating these components into established modular treatments such as 
CBIT or LWT, with the aim of enhancing outcomes. 
Tourette Syndrome research offers potential for future development in many areas 
including cross-culturally, via alternate delivery methods, using modular protocols, 
novel treatment components and multidisciplinary approaches. Large tic treatment 
trials and meta-analytic data have made a strong case for psychological treatments 
(Richards & Black, 2015). Robust, high quality research studies are now needed in 
order to support empirical expansion that addresses existing barriers to the clinical 
application of these methods. 
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ABSTRACT 
Aims 
Tourette Syndrome (TS) is a neurodevelopmental disorder characterised by the 
presence of both motor and phonic tics. It is often associated with psychiatric co-
morbidity, social and emotional difficulties, impaired school functioning and a 
diminished quality of life. Comprehensive Behavioural Intervention for Tics (CBIT) is 
a behavioural therapy with strong empirical support for its effects on tic severity 
when offered as an individual therapy, and emerging evidence for its effectiveness in 
a group format. Psychoeducational (PE) group interventions provide children with 
information about tics and target impairing psychosocial and co-morbid difficulties 
typically associated with TS. The objective of this study was to compare the long-
term effects of CBIT and PE groups. 
Method 
Twenty-eight participants with TS were assessed 12 months after completing a 
course of either group-based CBIT or PE. Participants completed measures 
assessing tic severity, self-reported quality of life (QOL) and neuropsychological 
functioning. School attendance data was also collected. 
Results 
Both groups demonstrated long-term improvement in tic severity which included 
significant continued improvement during the follow-up period (p = 0.012, p2=0.22). 
Long-term improvements were found for measures of self-reported QOL (p = 0.004, 
p2 = 0.25) and both groups showed significant post-treatment improvement in 
school attendance (p = 0.004, p2 = 0.30). An association between tic suppression 
ability and self-report QOL was observed at follow-up (r = -.52, p = 0.016). No 
systematic effects of either treatment were found on neuropsychological measures. 
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Conclusions 
Group-based interventions were associated with lower tic severity, improved quality 
of life and more frequent school attendance 12 months post-treatment. These 
results support the implementation of CBIT and PE group treatments for children 
with TS. 
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1. INTRODUCTION 
Diagnosis and epidemiology 
Tourette Syndrome (TS) is characterised by the presence of two or more motor tics 
and at least one phonic tic for a period of one year.  Tics are sudden, rapid, 
involuntary movements or vocal sounds that are often preceded by an aversive 
sensory experience, termed the premonitory urge (PU), which signals their onset. 
Common tics include eye blinking, sniffing and neck movements (McGuire et al., 
2015). Where only either motor or vocal tics are present, a diagnosis of chronic tic 
disorder (CTD) is described (American Psychiatric Association, 2013; ICD-10). 
The prevalence of TS is estimated at approximately 1% amongst 5-18 year olds 
(Robertson, 2008) with prevalence at least three times higher amongst males than 
females (Bitsko et al., 2014). Symptoms typically first present at ages 6-8 years 
(Peterson, Pine, Cohen & Brook, 2001) and reach peak severity between 10-12 
years, with an improvement in symptoms usually seen throughout late adolescence 
and adulthood (Pappert, Goetz, Louis, Blasucci, & Leurgans, 2003). 
Neurobiology 
The neurobiological nature of TS has been examined with the help of brain imaging 
and neurophysiological studies. Findings from these studies implicate the cortico-
striatal-thalamo-cortical (CSTC) pathways (Felling & Singer, 2011; Mink, 2001). An 
fMRI study conducted by Wang et al. (2011) demonstrated greater neural activity in 
motor pathways in TS subjects (sensorimotor cortex, putamen) compared to non-TS 
subjects, whilst decreased activity was observed in areas associated with the 
inhibitory control of motor pathways (caudate, anterior cingulate cortex). It was 
concluded that tics are likely generated by an increase in activity within the motor 
pathways and a decrease in activity in areas associated with inhibitory control. 
Diminished performance on neuropsychological tests of inhibitory control supports 
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this theory of TS (Deckersbach, Rauch, Buhlmann & Wilhelm, 2006; Watkins et al., 
2005).  
Conversely, Ganos et al. (2014) found no difference in action inhibition between TS 
and non-TS subjects, whilst Jackson et al. (2011) reported enhanced inhibition in TS 
subjects. They propose that enhanced inhibitory processes in TS subjects are 
evidence of compensatory adaptations to the prefrontal cortex developed as a result 
of repeated attempts at tic suppression and control. 
Conflicting findings make the neuropsychological correlates of TS difficult to 
determine and may be due to the variety of neuropsychological tests used, the 
broad range of ages tested, varying patient tic suppression ability, and the possible 
neural discrepancies between the causes and consequences of the disorder. 
Comorbidity may also play a mediating role, with some studies suggesting that 
inhibitory dysfunction is present only in TS patients with a comorbid disorder 
(Ozonoff, Strayer, McMahon & Filloux, 1998; Roessner, Becker, Banaschewski & 
Rothenberger, 2007). 
Despite research implicating several brain regions (e.g. caudate nucleus, 
sensorimotor cortex, anterior cingulate cortex), a principal site of tic generation is yet 
to be identified, leaving questions unanswered about the fundamental causes of TS 
(Felling & Singer, 2011; Gerard  & Peterson, 2003). 
Comorbidity 
Comorbid conditions are common amongst individuals with TS with ~50% 
presenting with a diagnosis of co-morbid obsessive compulsive disorder (OCD) or 
attention deficit hyperactivity disorder (ADHD; Abramovitch, Dar, Mittelman & 
Wilhelm, 2015; Bloch et al., 2006; Gaze, Kepley & Walkup, 2006). Other commonly, 
co-occurring difficulties include rage attacks, disruptive behaviour and social 
difficulties (McGuire et al., 2013; Sukhodolsky et al., 2003). These co-occurring 
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conditions compound the degree of functional, social and emotional impairment, 
impacting on the individual’s overall quality of life (QOL; Specht et al., 2011; Storch 
et al., 2007). Indeed, research has shown that individuals with TS exhibit a 
significantly reduced QOL when compared to the non-TS population (Eddy et al., 
2011; Müller‐Vahl et al., 2010; Storch et al., 2007). 
Quality of Life 
Further key contributors to a diminished QOL include a perceived pressure to adapt 
to society’s expectations, negative self-perception and the experience of being 
bullied (Cutler, Murphy, Gilmour & Heyman, 2009; Khalifa, Dalan & Rydell, 2010). 
Tic severity has also been found to be predictive of QOL (Cutler et al., 2009; Elstner, 
Selai, Trimble & Robertson, 2001; Evans, Seri & Cavanna, 2016), however Storch et 
al. (2007) found this effect to be present only in children with low levels of 
externalising behaviours. Recent research has identified a link between the ability to 
suppress tics and quality of life, finding that an individual’s satisfaction with their 
ability to control their tics is positively associated with enhanced QOL (Matsuda, 
Kono, Nonaka, Fujio & Kano, 2016). The authors argue that teaching strategies to 
patients to help them develop a sense of perceived control over their tics is key to 
improving QOL. 
Previously, interventions for individuals with TS were concerned primarily with the 
reduction of tic severity. In recent years, however, adaptations have been made to 
psychotherapeutic treatments to broaden the focus of therapy. Storch et al. (2012) 
developed a modular treatment protocol (‘Living with Tics’) that incorporates 
behavioural treatment with modules that focus on psychoeducation, problem-
solving, distress tolerance and coping at school, with the aim of improving tic-related 
impairment and resilience as well as tic severity. 
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Psychoeducation is a therapeutic approach that aims to increase the child’s 
understanding of TS as well as target the associated impairing psychosocial and co-
morbid difficulties. Topics can include self-esteem, school, anger, attention and 
OCD (Murphy & Heyman, 2007). It has been described as a significant therapeutic 
component when it comes to improving QOL, aiming to resolve misunderstanding 
around the diagnosis and alleviate anxiety (Cutler et al., 2009). Psychoeducation 
facilitated in a group format has also been described (Murphy & Heyman, 2007) and 
offers the added benefit of peer support as well as facilitating the sharing of 
information amongst individuals. Nussey, Pistrang and Murphy (2014) found that a 
classroom-based psychoeducational group was associated with more positive 
perceptions of TS in both children with TS, and their teachers and classmates. 
As the focus on QOL outcomes grows, it becomes increasingly important to 
determine the specific therapeutic components responsible for measurable 
psychosocial improvement. 
School functioning 
Storch et al. (2007) identified school to be the most commonly reported area of 
impairment amongst children with TS. Concentration in the classroom can be 
affected by the distracting nature of the tics and attempts to suppress tics during 
lessons may lead to fatigue and frustration (Packer, 2005). Children with TS are 
vulnerable to social isolation and bullying as a result of their symptoms, with one 
study reporting that up to 45% of children with tics experienced ‘teasing’ from peers 
(Debes, Hjalgrim & Skov, 2010). Certain practical tasks in the classroom, such as 
handwriting, can also be affected by frequent motor tics and a fifth of children have 
been shown to experience a level of tic severity that made functioning at school at 
times unfeasible, affecting school attendance (Leckman et al., 1998). These findings 
suggest that an improvement in tic severity may lead to an improvement in school 
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attendance rates, however, these are yet to be formally evaluated as a TS treatment 
outcome in children. 
Treatment 
Pharmacotherapy has traditionally been used to manage the symptoms of TS. Drug 
treatments such as typical and atypical antipsychotics (e.g. haloperidol, risperidone) 
and alpha-2 adrenergic agonists (e.g. clonidine, guanfacine) have been shown to 
significantly reduce tic severity (Weisman, Qureshi, Leckamn, Scahill and Bloch, 
2013). 
The European clinical guidelines for TS suggest that medication can lead to a 25 to 
50% reduction in tic symptoms. However, it is acknowledged that unlike 
psychotherapeutic interventions, medication does not offer long-term coping 
mechanisms to support and sustain improvement post-treatment (Roessner et al., 
2011). Furthermore, little is known about the impact of medication on the equally 
impairing psychosocial symptoms of TS (Woods et al., 2011). 
Treatment guidelines endorse behavioural therapy (BT) and psychoeducation as 
first line interventions for mild to moderate TS, recommending pharmacotherapy 
where behavioural interventions are not sufficient or unavailable (Steeves et al., 
2012; Van de Griendt, Verdellen, van Dijk & Verbraak, 2013). 
Habit Reversal Training (HRT; Azrin and Nunn, 1973) is arguably the most 
empirically supported behavioural approach, demonstrating medium to large 
treatment effects that are equivalent to effect sizes seen in drug trials of 
antipsychotic medication (Dutta & Cavanna, 2013; McGuire et al., 2014). Habit 
reversal training includes self-monitoring and awareness building components which 
aim to attune the patient’s awareness to the premonitory urge in order to facilitate 
early tic detection. Patients are then taught to apply a specific physically 
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incompatible movement or sound termed the ‘competing response’, in order to 
effectively block the production of the tic. 
Habit reversal training can be combined with relaxation training and functional 
analysis to create a multi-component intervention termed the ‘Comprehensive 
Behavioural Intervention for Tics’ (CBIT; Woods et al., 2008). 
Treatment outcomes 
Evidence supports the efficacy of CBIT when delivered face-to-face as an individual 
treatment (Piacentini et al., 2010; Wilhelm et al., 2012), as well as via telehealth 
(Himle et al., 2012; Ricketts et al., 2015). There is also emerging evidence for the 
efficacy of group-based CBIT (Yates et al., 2016). These latter protocols aim to 
increase the availability of behavioural treatments that can often be limited in their 
accessibility (McGuire et al., 2015). 
In addition to tic severity outcomes, Deckerbach et al. (2014) examined the effect of 
behavioural treatment on neuropsychological functioning, finding that TS adult 
patients demonstrated a significant decrease in motor pathway (putamen) activation 
when comparing fMRI findings from pre- and post- treatment. These findings 
indicate a degree of neuroplasticity and suggest that repeated practice of tic 
suppression (a key therapeutic component of BT) may lead to structural and 
functional changes to affected CSTC pathways. Further support for this comes from 
Morand-Beaulieu, O'Connor, Sauvé, Blanchet and Lavoie (2015) who found that 
CBT had a normalising effect on pre-treatment motor pathway abnormality detected 
in TS patients. Behavioural Inhibition was also monitored but remained unchanged 
post-treatment. 
Behavioural protocols have been found to significantly improve secondary 
psychosocial symptoms such as QOL (Woods et al., 2011), with findings indicating 
that children show a reduction in tic-related impairment following BT. Similiarly, 
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Deckersbach Rauch, Buhlmann and Wilhelm (2006) found improvements in life 
satisfaction ratings following a course of HRT in adult patients. 
Long-term outcomes 
Few studies have investigated the long-term durability of behavioural interventions. 
Of those studies that have carried out follow-up assessments, Wilhelm et al (2003) 
report the longest follow-up period (10 months) and describe a maintenance of post-
treatment improvement. Similarly, stability of treatment effects on tic severity has 
been reported at 6 month follow-ups in both children and adults (Himle et al., 2012; 
Piacentini et al., 2010; Wilhelm et al., 2012), whilst continued improvements have 
also been demonstrated for TS-related psychosocial symptoms (Woods et al., 
2011). 
It should be noted that much of the available follow-up data suffer high attrition rates 
(~30%) and has been limited to ‘treatment-responders’ only, suggesting a need for a 
conservative interpretation of findings. Furthermore, little is known about the long-
term efficacy of newer, adapted behavioural protocols designed to increase 
treatment availability, and at present, no follow-up observations have been 
conducted beyond 10 months. Due to the waxing and waning nature of tics, short-
term follow-ups may indirectly capture fluctuations in the natural course of symptom 
presentation and longer observation periods to account for these fluctuations have 
been recommended (Roessner et al., 2011). 
The present study 
Empirical support for the efficacy of behavioural interventions for TS, as well as the 
psychosocial benefits associated with group-based psychoeducation, makes a case 
for the potential benefits of group-based BT. 
A recent pilot randomised controlled trial (RCT) conducted by Yates et al. (2016) 
evaluated treatment outcomes for group-based CBIT and psychoeducation in order 
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to address the issue of limited treatment availability and explore the potential added 
psychosocial benefits of peer support. Improvements in tic severity and quality of life 
were reported for both treatment groups, with greater tic severity improvements for 
the CBIT group. Improvements in measures of behavioural inhibition were also 
observed in both group conditions and reported separately (Edwards, 2015). Good 
group attendance indicated the acceptability and feasibility of group treatment 
approaches, offering an effective treatment option for resource-limited services. 
Presently however, little is known about the long-term efficacy of group-based TS 
interventions. 
Aims and Objectives 
This study aims to examine the long term efficacy of group treatments (CBIT and 
PE) for TS by evaluating 12-month follow-up outcomes in patients originally 
assessed at post-treatment by Yates et al. (2016) and Edwards (2015). In doing so, 
the study also aims to contribute to the limited long-term evidence base for CBIT 
and PE tic treatments. 
Rationale 
This study will investigate whether improvements in tic severity and QOL following 
group treatment (as reported in Yates et al., 2016) are sustained after a 12-month 
follow-up period, as indicated by existing individual BT research (McGuire et al., 
2015; Piacentini et al., 2010). It will also aim to clarify the effect of behavioural 
treatment on inhibitory processes, an association which has to date produced 
conflicting findings (Edwards, 2015; Morand-Beaulieu et al., 2015). This study will 
investigate whether post-treatment improvements in a measure of behavioural 
inhibition (as reported in Edwards, 2015) are sustained at 12 months.   
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Additionally, based on recent research indicating a relationship between self-
perceived tic control and QOL (Matsuda et al., 2016), an objective measure of tic 
suppression ability will be examined as a potential predictor of QOL outcomes. 
Finally, this study will aim to investigate the relationship between tic treatment and 
school attendance in children. This relationship has yet to be formally evaluated 
however existing research linking tic severity to school attendance (Leckman et al., 
1998) indicates the potential for improvement in attendance following treatment. 
Hypotheses 
Hypothesis 1: Improvements in tic severity will be maintained at 12-month follow-up 
for both the CBIT group and the PE group, with the CBIT group exhibiting greater 
improvements than the PE group. 
Hypothesis 2: Improvements in QOL will be maintained at 12-month follow-up in 
both CBIT and PE groups. 
Hypothesis 3: Long-term quality of life (QOL) outcomes will be associated with tic 
suppression ability. 
Hypothesis 4: Improvements on a test of attention and inhibitory control will be 
maintained at 12-month follow-up in both groups. 
Hypothesis 5: Children in both groups will improve on school attendance in the 12 
months post-treatment compared with the 12 months prior to group treatment. 
 
2. METHOD 
2.1 THE WIDER PROJECT 
This follow-up study is part of a wider project that investigated the short-term effects 
of group-based interventions for TS. The original study was designed and developed 
as part of two D.Clin.Psy theses. Edwards (2015) investigated the effects of group 
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interventions on tic severity and neuropsychological functioning, whilst Yates et al. 
(2016) explored the impact of these interventions on tic severity and quality of life 
outcomes. The original study provided the Time 1 and Time 2 outcomes cited in this 
report. This study explores tic severity, quality of life and neuropsychological 
outcomes at 12 months post-treatment. It also examines the impact of group 
treatment on school attendance, an additional element to the wider project that was 
not previously investigated. 
The wider project includes contributions from three trainee clinical psychologists, 
including the author. A breakdown of trainee contributions is provided in Appendix A. 
2.2 DESIGN 
This follow-up study is part of a pilot randomised controlled trial (RCT) designed to 
test the feasibility and acceptability of a future larger, multi-site RCT. This study has 
a cross-sectional design, collecting data at a single time point (time 3). The data, 
however, forms part of a larger longitudinal data set and will be analysed together 
with previously collected data from time 1 (pre-treatment) and time 2 (post-
treatment). 
The project has a single-blinded, randomised and controlled design. Participants 
were pre-allocated to either CBIT or PE group treatment using a randomisation 
method as part of the original study. Group allocation was maintained for the follow-
up. Data analysis used a repeated-measures design with three time points (pre-
treatment, post-treatment and 12-month follow-up).  
 
2.3 ETHICAL CONSIDERATIONS 
All participants received a letter informing them about the study followed by a phone 
call a few weeks later offering the opportunity to ask any study-related questions. 
Families were informed that they were under no obligation to participate in the 
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follow-up study and that their decision would not affect their clinical care. Families 
that chose to participate gave verbal consent to the study during the telephone call 
and parental written consent and child written assent was obtained at the start of the 
follow-up assessment. Children were given the opportunity to ask any questions 
prior to the assessment and were reminded that they could opt-out of the study at 
any time. See Appendix B for further details of ethical considerations. 
2.4 ETHICAL APPROVAL 
The original study was approved by London Queen Square Research Ethics 
Committee and the hospital’s research and development department. The original 
ethics application included a planned follow-up study and this was approved. Prior to 
commencement of the follow-up, modifications to the original protocol were made 
and these were submitted as a major amendment by the author and were reviewed 
and accepted by the ethics committees (see Appendices C and D). 
2.5 AFFILIATIONS AND FUNDING 
This trial was registered on the National Institute for Health Research Portfolio 
Database (ISRCTN: 50798741). Funding for the follow-up trial was provided by 
University College London and Tourettes Action, UK (a national TS charity). 
Tourettes Action did not contribute to any aspect of the study’s design, execution, 
data analysis or reporting. University College London provided guidance and 
supervision for this project. 
 
2.6 PARTICIPANTS 
A total of 33 participants took part in the original trial. Participants were children that 
had been referred to and seen by the tic disorder clinic in the preceding 5 years to 
the study. Eligible participants were aged 9-13 years (to coincide with the peak tic 
severity period), with a primary diagnosis of TS or CTD, a baseline score of >13 on 
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the Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989) and a full-scale 
IQ >80. Exclusion criteria included a current or lifetime diagnosis of psychosis or 
substance abuse and children who had previously received more than four sessions 
of behavioural treatment for tics or had attended a psychoeducational session at the 
tic clinic within the past 2 years. Families whose level of English language 
proficiency would render it difficult to follow sessions were also excluded.  Children 
who were successfully recruited were assigned to either CBIT or PE group 
treatment arms. The treatment interventions commenced in October 2013 and 
January 2014. Participants were randomised and stratified to ensure equal group 
allocations for age and gender. 
All participants who participated in the original trial were eligible for inclusion in the 
follow-up study unless they had withdrawn during the trial1. Twenty-nine of the 
original study participants were contacted for follow-up recruitment and 28 
participants agreed to participate2. Recruitment for the follow-up study took place 
between October 2014 and January 2015. 
2.7 INTERVENTIONS 
Both group treatments consisted of eight sessions conducted on a once-weekly 
basis. The first two sessions of each group were 90 minutes long, with the 
remainder of sessions running for 60 minutes each. Sessions comprised of 
psychologist-led components as well as interactive group discussions and activities. 
Both treatment groups included the same initial session on psychoeducation about 
tics and both included a relaxation training component. Groups were matched on 
overall structure, therapist exposure, use of reward strategies and the amount of 
homework set each week. In order to maintain consistency across groups, a 
                                                          
1 Four participants withdrew from the original trial prior to post-treatment assessment (time 
2). 
2 One participant was uncontactable having moved address and changed telephone number 
without informing the clinic. 
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Paediatric Neuropsychologist (TM) with over 10 years of experience of working at 
the specialist tic clinic, facilitated both treatment groups. 
Alongside the child CBIT and PE groups, parents attended four parallel intervention 
group sessions that were linked to either the child CBIT group or the PE group 
depending on their child’s group allocation. Parent group sessions included either 
CBIT-specific or PE-specific content designed to complement the content of their 
child’s group, including information about tics, group discussions and advice on the 
use of reward strategies with their child. 
The CBIT group treatment was developed from a combination of the individual CBIT 
treatment protocol (Woods et al., 2008) and the HRT parent workbook (Verdellen, 
van de Griendt, Kriens & van Oostrum, 2011). The PE group treatment was based 
on a protocol developed by Murphy and Heyman (2007). See Appendix E for further 
details on the content of interventions. 
 
2.8 OUTCOME MEASURES 
Measures used in the current study are reported. Several additional measures were 
administered during the follow-up assessment in accordance with the wider project 
but did not form part of the current study. These additional measures are cited in the 
assessment protocol (see Appendix F). 
2.8.1 Tic severity 
Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989) 
The YGTSS is a semi-structured, clinician-administered interview with good internal 
consistency, inter-rater reliability and validity in paediatric TS populations. It is 
considered the gold-standard measure of tic severity (Storch et al., 2005; 
Abramovich et al., 2015) and is the primary outcome measure for this study. The 
YGTSS collects information on tic symptoms over the last week and scores these 
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for number, frequency, intensity, interference and complexity. There is also a 
separate impairment scale. See Appendix G for a copy of the YGTSS. 
The lead assessor (a trainee clinical psychologist) was trained in YGTSS 
administration by a consultant clinical psychologist (TM) who has over 10 years of 
experience administering the YGTSS at a national tic clinic. TM also trained the 
YGTSS assessors at Time 1 and Time 2. 
- Inter-rater reliability 
All YGTSS interviews were audio recorded and 10% were later re-rated to test for 
inter-rater reliability. A random number generator website 
(https://www.randomizer.org/) was used to identify the three YGTSS interviews that 
would be double rated by a consultant clinical psychologist (TM). An overall 
agreement percentage was obtained by calculating the mean difference between 
scores for each double-rated YGTSS interview. Percentage agreement was 
calculated at 96% indicating strong inter-rater reliability. 
Video Observation of tic expression and tic suppression 
Video observations were carried out in order to calculate tic suppression ability. 
Children were seated in front of a laptop that screened 20 minutes of a Simpsons 
episode whilst the in-built laptop webcam captured a video of the participant’s head 
and upper torso area. The Simpsons episode was carefully chosen and matched to 
the two previous episodes watched by participants at T1 and T2. Further details of 
the episode selection process are provided in Appendix H. 
After 15 minutes, the episode was paused and the video recording was ended. 
Participants were then asked to attempt to suppress their tics as much as they felt 
able to for the following 5 minutes, after which they would receive a small reward (a 
bouncy ball). The episode and video recording was then continued for a further 5 
minutes. 
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The protocol used for video observation in this study closely followed the 
methodology used in the original study, which was based on a protocol described 
and reported by Himle et al. (2006). In addition, the principal investigators from the 
original study trained the follow-up assessor in order to increase stability and 
consistency of observation methods. 
Tic frequency was measured for each condition by calculating the average number 
of tics observed per minute. The percentage change in tic frequency between the tic 
expression and tic suppression conditions was then calculated in order to calculate 
a measure of suppression ability, 
2.8.2 Quality of life 
The Gilles de la Tourette syndrome-quality of life scale for children and adolescents 
(C&A-GTS-QOL; Cavanna et al., 2013). 
The C&A-GTS-QOL is an Italian 27-item measure of health-related quality of life in 
children with TS. It consists of four subscales (psychological, physical, obsessive-
compulsive and cognitive) as well as a separate life satisfaction scale. This study 
used an English translation of the measure which has been shown to have good 
acceptability, reliability (Cronbach’s alpha > 0.7) and validity (Su et al., 2016). See 
appendix I for a copy of the C&A-GTS-QOL. 
2.8.3 Neuropsychological functioning 
Neuropsychological functioning was measured using the NIH Toolbox 
(www.nihtoolbox.org), which is a set of brief, computerised measures used to 
measure changes in neurological function over time. These measures are nationally 
standardised to the US population, normed for ages 3-85 years and demonstrate 
good convergent and discriminant validity (Weintraub et al., 2013; Beaumont et al., 
2013). 
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For the administration of the first two tests (the Dimensional Change Card Sort test 
and the Flanker Inhibitory Control and Attention Test), children were seated at a 
table in front of a computer screen and keyboard. The assessor controlled the 
computer screen from a laptop that ran the online NIH Toolbox software. Each task 
included a set of standardised instructions and a brief practice period. Visual stimuli 
were presented on the screen and remained there until a response was made. 
Participants were asked to respond with their dominant hand using either the right or 
left arrow buttons on the keyboard. Age-adjusted scaled scores were automatically 
calculated and made available in an online database. 
The Dimensional Change Card Sort test (DCCS) and Flanker Inhibitory Control and 
Attention Test were chosen as measures of executive function and attention. 
Specifically, they measured an individual’s ability to switch focus between multiple 
aspects of a task (set shifting) and the individual’s ability to inhibit any automatic 
responses that may delay task completion. The 9-Hole Pegboard Test was chosen 
as a measure of motor dexterity. Specifically, it measures finger coordination and 
the individual’s ability to skilfully handle objects under time pressure. 
Dimensional Change Card Sort test (DCCS) 
This is a measure of cognitive flexibility and takes approximately four minutes to 
administer. Participants were shown a picture in the centre of the screen followed by 
a set of two further pictures that appeared below. Participants were asked to select 
one picture from the pair that matched the original central image according to one of 
two rules (colour or shape). Participants were asked to match first according to 
shape and then according to colour. A third round of trials involved participants 
switching between shape and colour rules at random dependent on instructions on 
the computer screen. 
Flanker Inhibitory Control and Attention Test 
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This is a measure of attention and inhibitory control and takes approximately three 
minutes to administer. It is a timed task and requires the participant to attend to a 
central stimulus (arrow pointing either left or right) whilst inhibiting attention to any 
stimuli flanking it. Flankers are either congruent or incongruent and the participant is 
asked to respond in accordance with the central stimulus. 
Pegboard Dexterity Test 
This is a measure of manual dexterity and takes approximately four minutes to 
administer. It measures the time taken for an individual to accurately place nine 
pegs one at a time into a nine-hole pegboard, and then remove each peg one-by-
one.  
2.8.4 School attendance 
School contact information was obtained from families during the follow-up 
assessment. Each participant’s school was then contacted in order to obtain school 
attendance data (% attendance) for the full academic year prior to group attendance 
(September 2012 – July 2013) and the full academic year following group 
participation (September 2014 – July 2015). 
2.8.5 Significant life events, medication changes and further treatment 
Participants were asked to provide information about any medication changes, 
significant life events or further psychological treatment of tics that may have 
occurred in the 12 months between the end of the intervention and the follow-up 
assessment. Information was recorded on a separate questionnaire (see Appendix 
J) completed by the parent. 
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2.9 PROCEDURE 
Participants were informed about the 12-month follow-up assessment during the 
original study and each family was asked whether they would like to be contacted to 
participate in the follow-up at the T2 assessment. All families agreed to be 
contacted. 
Families were initially sent a letter outlining details of the follow-up study (see 
Appendix K) accompanied by both a parent and child information sheet (see 
Appendices L and M). This was followed up three weeks later with a telephone call 
which offered the opportunity for families to ask questions about participation in the 
study. If they agreed to participation, a home-based follow-up assessment was 
organised over the telephone.  
The complete battery of tests was administered by the same assessor in a single 
session based in a quiet room at the child’s home. Assessments lasted 
approximately 3 hours. The assessor followed the same structured assessment 
protocol used in the original study in order to maintain consistency and reliability of 
assessment. 
Prior to the assessment, the assessor checked that both the parents and children 
had understood the information provided about the assessment and checked 
whether they had any questions. Children were shown a visual plan of the day (see 
Appendix N) and consent and assent forms (see Appendices O and P) were 
completed and collected. 
All follow-up assessments were carried out approximately 12 months after the post-
treatment assessment (time 2) and within 30 days of the 12-month mark, with the 
exception of one participant who attended the PE group3. Assessments were 
                                                          
3 For this case, the time 2 assessment was delayed by 14 weeks. The time 3 assessment 
was conducted in line with the original time 1 assessment, and therefore 10 months after 
time 2. 
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completed by March 2015 and school attendance data collection was completed by 
December 2015. 
 
2.10 RANDOMISATION AND BLINDING 
 
Participants were randomised to treatment groups at the start of the original study. 
Families were not blind to treatment allocation due to the distinguishable topics and 
concepts covered within group sessions. The principal assessor was not involved in 
any aspect of the original study and remained blind to group allocation throughout 
the follow-up study. 
Blinding was maintained by ensuring that participant group allocation details were 
stored separately from the main database in a password-protected file that the 
principal assessor did not have access to during the study. The assessor informed 
families when arranging follow-up assessments and again at the start of the 
assessment that they were blind to treatment allocation and explained the 
importance of not disclosing which group the child had participated in. 
- Success of blinding 
The success of blinding is considered a key determinant of a clinical trial’s validity 
(Bang, Ni & Davis, 2004). Blinding success was calculated for each treatment arm 
using Bang’s Blinding Index (BI; Bang et al., 2004; Williamson, Harvill & Stamey, 
2013) based on the assessors allocation guesses for each participant. Bang’s BI is 
treatment arm-specific and has a range of -1 to 1, where 0 represents perfect 
blinding, 1 represents complete unblinding (every group allocation guessed 
correctly) and -1 indicates complete opposite guessing (every group allocation 
guessed incorrectly) which could also be an indicator of unblinding. 
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A BI of 0.38 was calculated for the CBIT condition, indicating that 38% of allocation 
guesses were correctly guessed beyond chance. For the PE condition, Bang’s BI 
was calculated as -0.15, indicating that 15% of guesses were incorrect beyond 
chance. There is no specific range of BI that indicates acceptable blinding (Kolahi, 
Bang and Park, 2009) although smaller values (positive or negative) will indicate 
strength of blinding. Bang’s blinding indices for the two treatment conditions indicate 
that for the majority of participants, blinding was successful, however blinding may 
have been unsuccessful for a few cases in the CBIT condition (see Table 1). 
 
Table 1 
Number of subjects by actual group allocation and guessed group allocation 
Actual allocation 
 
Guessed allocation 
n (%) 
Total 
n (%) 
 CBIT PE Don’t know  
CBIT 8 (28.6) 3 (10.7) 4 (14.3) 15 (53.6) 
PE 5 (17.9) 3 (10.7) 5 (17.9) 13 (46.4) 
Total 13 (46.4) 6 (21.4) 9 (32.1) 28 (100.0) 
Note. Blinding index (CBIT:PE) = 0.38 : −0.15 
 
 
2.11 SAMPLE SIZE AND POWER 
The sample size for the follow-up study was limited to participants that had 
completed the original study (N = 29). There was one dropout between T2 and T3, 
therefore the follow-up study had a predetermined sample of N = 28. A medium 
effect size (f=0.25) was estimated based on results from the original study (Yates et 
al., 2016). A post hoc analysis was used to estimate achieved power for a repeated 
measures mixed model ANOVA with two groups and one primary outcome measure 
(YGTSS) taken at three time points. Power calculations were made using 
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“G*Power3” statistical software (Faul, Erdfelder, Lang & Buchner, 2007) based on 
an alpha level of 0.05, nonsphericity correction at 1 and correlation among repeated-
measures at 0.5. The analysis estimated power = 0.81 for this study, which is by 
convention considered sufficient to minimise the risk of incurring a type II error 
(Cohen, 1992). 
2.12 STATISTICAL ANALYSIS 
Data was analysed using IBM SPSS version 21.0. A completers-only analysis 
(N=28) was conducted in accordance with previous follow-up analyses (Wilhelm et 
al., 2003; Deckersbach et al., 2006) in which only participants for whom data was 
available at all three time points were included. A responders-only analysis 
(participants who had responded positively to treatment) was also considered in line 
with previous studies (Woods et al., 2011, Piacentini et al., 2010), however was 
ultimately not used in this study in order to preserve sample size and statistical 
power. 
Prior to outcome analysis, data was screened for missing values, tests of normality 
were conducted, and statistical outliers were removed where appropriate. Where the 
assumption of normality was not met, this was corrected for and described 
alongside any reported results. 
Baseline descriptive data was analysed and independent samples t-tests and 
Fischer’s Exact tests were used to check for any significant baseline group 
differences. Parametric tests were used throughout the main analysis having 
established that data met the relevant test assumptions. 
The primary hypothesis was analysed using 2 x 3 mixed model repeated measures 
Analysis of Variance (ANOVA) tests, with ‘group condition’ as the between subjects 
factor (CBIT, PE) and ‘time’ as the within-subjects factor (pre-treatment, post-
treatment and 12-month follow-up). Partial eta-squared effect sizes (p2) were 
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reported4. Secondary hypotheses were analysed using 2 x 3 mixed model repeated 
measures ANOVA tests and Pearson’s correlations5. Where multiple comparisons 
were made using one outcome measure, significance levels were adjusted using 
Bonferroni corrections to control for an inflated familywise error rate. 
 
3. RESULTS 
Follow-up assessments took place between November 2014 and March 2015 with 
all participants remaining in their pre-assigned group conditions. Twenty-eight 
participants took part in the follow-up study out of a total of 33 participants recruited 
at time 1. The five dropouts6 did not significantly differ from completers on measures 
of baseline tic severity (d = 0.18, p = 0.73). Participants ranged in age from 10 - 14 
years (mean = 12.06, SD = 1.38). 
3.1 CONSIDERATION OF POTENTIAL CONFOUNDS 
3.1.1 Attendance rates 
Of the 28 follow-up participants, 26 were considered treatment ‘attenders’ (attending 
at least five out of eight treatment sessions). The two participants attending less 
than five sessions were both from the PE group and attended two and four sessions, 
respectively. Children in the CBIT group attended a mean of 7.53 sessions (SD = 
0.52) with a mode of 8 sessions, compared with 7.2 sessions (SD = 1.9) in the PE 
group with a mode of 8 sessions. Difference in group attendance between the two 
                                                          
4 Rules of thumb taken from Murphy and Myors (2004) suggest effect size magnitudes: 0.01 
= small effect size, 0.06 = medium effect size, 0.14 = large effect size. 
5 Rules of thumb taken from Cohen (1988) for Pearson’s correlation coefficient suggest 
effect size magnitudes: 0.1 = small effect size, 0.3 = medium effect size, 0.5 = large effect 
size. 
6 The five dropouts consisted of four participants that did not complete the original study and 
one participant that completed the original study but was not recruited for the follow-up. 
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conditions was considered small and therefore no adjustments were made during 
analysis. 
3.1.2 Tic medication changes 
Four participants (3 CBIT, 1 PE) reported tic medication changes over the previous 
12 months. Three participants had stopped taking medication due to an 
improvement in tic symptoms and one participant reported reducing their dosage. 
Previous studies have found no evidence of tic medication acting as a moderator to 
behavioural treatment outcomes (Piacentini et al., 2010; McGuire et al., 2014) and 
therefore the four changes in medication status were not statistically accounted for 
in analysis. 
3.1.3 Significant life events 
Seven participants reported significant life events during the follow-up period. Four 
participants reported family-related issues, one participant reported stress caused 
by school exams, one reported a depressive episode, and one participant reported 
being off school for three months due to physical illness. The analysis was re-run to 
exclude participants that reported significant life events. Where changes to findings 
were observed, these are reported. 
3.1.4 Further psychological treatment 
Thirteen participants engaged in psychological treatment unrelated to the study 
during the follow-up period. The focus of therapy varied amongst participants (3 
generalised anxiety, 1 phobia, 4 OCD, 1 low mood, 2 anger, 1 ‘physical symptoms 
not related to TS’ and 1 ASD). No participants reported engaging in further 
psychological therapy for tics specifically. 
Exposure and response prevention, a therapy typically used to manage OCD 
symptoms, is also an evidence-based treatment for tics (Verdellen et al., 2011). It is 
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therefore possible that participants benefitting from ERP treatment for OCD 
symptoms during the follow-up period (PE = 4, CBIT = 0) may have experienced 
additional therapeutic benefits to tic symptoms. For this reason, all analyses were 
re-run excluding the four participants that had received ERP for OCD. Where 
changes to findings were observed, these are reported. 
3.1.5 Age 
Tic symptoms gradually remit throughout adolescence for the majority of individuals 
(Hassan & Cavanna, 2012). This natural remission should be taken into 
consideration when investigating the long-term effects of treatment and efforts 
should be made to distinguish natural remission from the effects of the intervention 
when evaluating treatment efficacy. 
The mean age of participants in this study was 10.80 (SD = 1.39) at baseline (T1) 
and 12.06 (SD = 1.38) at follow-up (T3). Peak severity of tic symptoms has typically 
been observed at approximately 10-12 years (Bloch et al., 2006; Leckman et al., 
1998). In accordance with the literature, the current sample of participants was 
assessed across three time points all within the ‘peak period’ of tic symptoms. This 
suggests that an effect of natural remission would not necessarily be expected. In 
addition, age-matched randomisation across groups should further obviate any 
effect.  
3.2 NORMALITY, OUTLIERS AND MISSING VALUES 
Outcome variables were screened to check for normal distribution using 
Kolmogorov-Smirnov tests of normality. All data was normally distributed with the 
exception of T2 CBIT group data for the DCST and Flanker neuropsychological 
outcome variables. This data was normalised following the removal of an outlier 
(participant #33). Two further statistical outliers (participant #2, PE group; participant 
#3, CBIT group) were found and removed from the tic counting data. 
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Follow-up tic counting data and neuropsychological outcome data was missing for 
participant #11 who only agreed to complete the questionnaires at T3, and school 
attendance data was not available for participants #3, #7 and #117. 
3.3 BASELINE CHARACTERISTICS 
Baseline characteristics for the 28 follow-up participants are presented as 
categorical and continuous data in Tables 2 and 3, respectively. Participants in the 
two conditions did not differ significantly on demographic or clinical characteristics, 
with the exception of baseline tic suppression ability (calculated as a percentage 
using tic frequencies from suppression and non-suppression video observations). At 
baseline, the PE group demonstrated significantly better suppression ability than the 
CBIT group (p = 0.01). This significant baseline difference between groups should 
be held in mind and related results should be interpreted with caution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
7 Attendance data missing due to schools not responding to data requests. 
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Table 2 
Categorical descriptive data and group differences for participant characteristics at 
baseline 
Demographic and clinical 
characteristics 
Group Fisher’s 
Exact 
Test 
All (n = 28) Psych-Ed 
(n = 13) 
CBIT (n = 15) p* 
Male gender (n, %) 
 
21 75% 10 76.9% 11 73.3% 1.00 
Ethnicity (n, %)       1.00a 
 White British 19 67.9% 9 69.2% 10 66.7%  
 Other White 6 21.4% 3 23.1% 3 20%  
 British Indian 1 3.6% 1 7.7%    
 Black British 1 3.6%   1 6.7%  
 Mixed/ multiple ethnic 1 3.6%   1 6.7%  
Tic disorder (n, %)       0.48 
 TS 26 92.9% 13 100% 13 86.7%  
 CMTD 2 7.1%   2 13.3%  
Right handed (n, %) 24 85.7% 11 84.6% 13 86.7% 1.00 
Comorbidity (n, %)        
 ADHD diagnosis 6 21.4% 4 30.8% 2 13.3% 0.37 
 OCD diagnosis (based 
on parent impairment 
rating reaching clinical 
cut-off, see below) 
8 28.6% 5 38.5% 3 20% 0.41 
Other diagnoses b        
 ASD 2 7.1% 1 7.7% 1 6.7%  
 Anxiety/panic 2 7.1%   2 13.3%  
 Dyspraxia 2 7.1% 1 7.7% 1 6.7%  
 Dyscalculia 1 3.6% 1 7.7%    
 Epilepsy 1 3.6%      
Month group began (n, %)       0.71 
 September 15 53.6% 6 46.2% 9 60%  
99 
 
Demographic and clinical 
characteristics 
Group Fisher’s 
Exact 
Test 
All (n = 28) Psych-Ed 
(n = 13) 
CBIT (n = 15) p* 
 November 13 46.4% 7 53.8% 6 40%  
Tic medication at T1 (n, %)  10 35.7% 3 23.1% 7 46.7% 0.25 
Change in tic medication 
between T2 and T3 c 
4 14.3% 1 7.7% 3 20% 0.60 
Sig. life event(s) between 
T2 and T3 c 
7 25% 4 30.8% 3 20% 0.67 
*All two-tailed 
a Fisher’s exact test conducted using pooled ethnicity data (White British vs other) 
in a 2 x 2 contingency table. 
b Fisher’s exact test not conducted as frequencies too small. 
c Data collected at T3 assessment. 
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Table 3 
Continuous descriptive data and group differences for participant characteristics at 
baseline 
 Group Independent-
samples t-test 
 All (n = 
28) 
Psych-Ed 
(n = 13) 
CBIT (n 
= 15) 
 M (SD) M (SD) M (SD) p-value* 
Age (years) 10.80 
(1.39) 
10.67 
(1.46) 
10.91 
(1.37) 
0.66 
Full-scale IQ 102.89 
(12.86) 
105.15 
(13.63) 
100.93 
(12.29) 
0.40 
SES total score 41.56 
(14.48) 
46.42 
(15.92) 
37.35 
(12.08) 
0.10 
YGTSS     
 Motor tic 
severity 
16.82 
(4.00) 
15.92 
(3.23) 
17.60 
(4.53) 
0.28 
 Phonic tic 
severity 
12.61 
(6.72) 
12.92 
(6.41) 
12.33 
(7.19) 
0.82 
 Tic severity 
score 
29.43 
(9.29) 
28.85 
(8.70) 
29.93 
(10.05) 
0.76 
 Total tic score 51.21 
(15.59) 
49.62 
(16.08) 
52.60 
(15.57) 
0.62 
Tic observation (tics 
per minute) 
7.29 
(4.19) 
8.21 
(4.20) 
6.50 
(4.16) 
0.29 
Tic suppression (tics 
per minute) 
6.22 
(3.77) 
5.58 
(3.82) 
6.77 
(3.76) 
0.42 
Suppression ability 13.57 
(44.59) 
34.84 
(36.78) 
-6.17 
(43.07) 
0.01 
Neuropsychological 
functioning a 
    
 DCST 101.69 
(12.76) 
104.63 
(11.42) 
99.15 
(13.69) 
0.27 
 Flanker test 98.67 
(11.36) 
96.78 
(8.99) 
100.30 
(13.17) 
0.42 
 Motor dexterity  100.11 
(13.97) b 
103.04 
(16.76) e 
97.96 
(11.67) 
0.37 
GTS-QoL total score 34.11 
(15.74) 
36.15 
(14.37) 
32.33 
(17.14) 
0.53 
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 Group Independent-
samples t-test 
 All (n = 
28) 
Psych-Ed 
(n = 13) 
CBIT (n 
= 15) 
 M (SD) M (SD) M (SD) p-value* 
GTS-QoL 
satisfaction score 
74.50 
(15.18) 
72.23 
(14.34) 
76.47 
(16.11) 
0.47 
School attendance 
(%) 
93.08 
(4.94) c 
93.69 
(4.11) d 
92.60 
(5.62) 
0.58 
* All two-tailed 
a Age-adjusted scaled scores 
b N = 26 due to missing data (CBIT = 15; Psych-Ed = 11) 
c N = 27 due to missing data (CBIT = 15; Psych-Ed = 12) 
d N = 12 due to missing data 
e N = 11 due to missing data 
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3.4 MAIN ANALYSIS 
All analyses incorporated three time points (T1, T2 and T3) unless otherwise stated. 
Where significant effects are observed, a secondary, exploratory analysis was 
conducted to determine any continued changes occurring specifically during the 
follow-up period, between T2 and T3. 
Hypothesis 1: Improvements in tic severity will be maintained at 12-month 
follow-up for both groups, with the CBIT group exhibiting greater 
improvements than the PE group. 
A series of four 2 X 3 mixed model Repeated Measures Analysis of Variance (RM-
ANOVA) tests were conducted to analyse the effects of time (T1, T2 and T3) and 
group condition (CBIT and PE) on tic severity, as well as any group-time 
interactions. The outcome variables that were analysed included subscales of the 
YGTSS (motor tic severity, phonic tic severity, total tic severity) as well as the 
YGTSS total score. Where the assumption of sphericity has not been met, 
Greenhouse-Geisser corrections are reported. Findings from four RM-ANOVA tests 
are presented in Appendix Q. 
A significant main effect of time was observed for the motor tic severity score 
(F(1.5,39) = 15.23, p < 0.001, p2=0.37, large effect size; see Figure 1). The 
assumption of sphericity was violated and the Greenhouse-Geisser correction is 
reported with adjusted degrees of freedom. There was no significant effect of group, 
however a significant polynomial linear contrast for the interaction was observed 
(F(1,26) = 4.40, p = 0.046, p2 = 0.15, large effect size), suggesting an interaction 
effect between time and group. In this case, inspection of the plot indicates that 
there was greater reduction in motor tic severity over time in the CBIT group, 
however, this interaction is only just significant and should be interpreted 
conservatively.   
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Figure 1: Main effect of time on the YGTSS motor tic severity subscale  
 
 
 
A significant main effect of time was also observed for phonic tic severity scores 
(F(2,52) = 4.76, p = 0.013, p2=0.16, large effect size), total tic severity scores 
(F(2,52) = 12.25, p < 0.001, p2=0.32, large effect size) and YGTSS total scores 
(F(2,52) = 7.38, p = 0.002, p2=0.22, large effect size; see Figure 2). All findings 
survived Bonferroni correction (p ≤ 0.013). The effect of group condition was not 
significant for any of these outcome measures and no significant group-time 
interactions were found, indicating that there were no significant differences in tic 
severity improvement between the two groups. 
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Figure 2: Main effect of time on YGTSS total scores  
 
 
 
An average 8 point reduction on the YGTSS tic severity score was observed 
between T1 and T3 for the CBIT condition, compared to a 6 point reduction in the 
PE group. These findings suggest that both groups experienced significant symptom 
improvement in the period between pre-treatment and follow-up, as defined by 
Storch et al. (2011) who recommend a 6 point change on the YGTSS tic severity 
score as the best indicator of treatment response. 
Jeon et al (2013) propose that a 25% reduction in an individual’s tic severity score 
(the combination of the motor and phonic tic severity subscales) represents a 
clinically meaningful change or a ‘responder’. In accordance with this proposed 
benchmark, 46.2% (n = 6; range of tic reduction = -12.5% to 63.0%) of participants 
in the PE group would be considered treatment “responders”, whilst 53.3% (n = 8; 
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range of tic reduction = -23.8% to 70.6%) would be considered “responders” in the 
CBIT group, when measuring symptom change between T1 and T3. 
Exploratory analysis 1: 
Inspection of the line graphs indicated continued improvement on the YGTSS 
between T2 and T3 which was not specifically hypothesised, but nonetheless would 
be useful to determine. 
A series of four RM-ANOVA tests were conducted to test for ongoing changes in 
outcome variables (YGTSS motor tic severity, phonic tic severity, total tic severity 
and total score) between T2 and T3. These analyses used a 2 X 2 mixed model 
design to observe the effects of time (T2 and T3) and group condition (CBIT and 
PE) as well as any group-time interactions.  
A significant effect of time was observed for motor tic severity scores (F(1,26) = 
7.52, p = 0.011, p2=0.22, large effect size) and total tic severity scores (F(1,26) = 
7.25, p = 0.012, p2=0.22, large effect size) but no significant effects of group 
condition or group-time interactions were observed for either outcome measure. 
Complete results from the four RM-ANOVA tests are presented in Appendix R. 
These results demonstrate continued improvements in tic severity in both group 
conditions over the follow-up period, with an observed reduction of four points and 
five points on the YGTSS tic severity scale for the PE and CBIT groups, 
respectively. There were no significant differences in improvement between groups 
across the follow-up period. 
Hypothesis 2: Improvements in QOL will be maintained at 12 month follow-
up for both the CBIT group and the PE group. 
GTS-QOL total scores were used as a measure of self-reported QOL and were 
analysed using a 2 x 3 RM-ANOVA test. A mixed model design was implemented 
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with group condition (CBIT and PE) as the between-subjects factor and time (T1, T2 
and T3) as the within-subjects factor. There were no main effects of time (F(2,52) = 
2.31, p = 0.109), group condition (F(2,52) = 1.27, p = 0.27) or group-time interaction 
(F(2,52) = 0.68, p = 0.511). 
A secondary analysis was conducted excluding cases that had reported significant 
life events during the follow-up period (n = 7). Results of this analysis showed a 
significant main effect of time on GTS-QOL total scores (F(2,52) = 6.35, p = 0.004, 
p2 = 0.25, large effect size). Results from the RM-ANOVA test are presented in 
Table 4 and depicted in Figure 3. 
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Table 4 
2 x 3 ANOVA test of GTS-QOL scores for hypothesis 2 
 Psych-Ed (N = 9) CBIT (N = 12) Main 
effect of 
group 
Main 
effect 
of time 
Inter-
action 
All (N = 21) 
 T1 T2 T3 T1 T2 T3    T1 T2 T3 
 M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
p p p M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
GTS-QOL 
total score 
39.00 
(16.15), 
26.59 – 
51.41 
34.11 
(7.62), 
28.25 – 
39.97 
27.00 
(13.90), 
16.31 – 
37.69 
33.25 
(18.83), 
21.29 – 
45.21 
28.33 
(16.89), 
17.60 – 
39.07 
25.17 
(16.93), 
14.41 – 
35.92 
 
0.480 
 
0.004 
 
0.725 
35.71 
(17.54), 
27.73 – 
43.70 
30.81 
(13.74), 
24.56 – 
37.06 
25.95 
(15.35), 
18.96 – 
32.94 
Note. N = 21 (participants reporting significant life events excluded from analysis) 
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Figure 3: Main effect of time on GTS-QOL total scores  
 
Exploratory Analysis 2: 
Inspection of the line graph indicated continued improvement on the GTS-QOL 
between T2 and T3. This was not specifically hypothesised but would be useful to 
statistically determine. 
A 2 x 2 mixed model RM-ANOVA excluding cases with significant life events (as 
above) was conducted to analyse changes in QOL during the follow-up period (T2 
and T3) with time (T2 and T3) as the within-subjects factor and group (CBIT and PE) 
as the between-subjects factor). A significant main effect of time was observed 
(F(1,19) = 5.73, p = 0.027, p2 = 0.23, large effect size). These findings indicate that 
both groups demonstrated continued improvement in QOL during the 12 months 
after completing group treatment, with a 7 point improvement observed in the PE 
condition whilst the CBIT group improved by an average of 3 points. 
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Hypothesis 3: Long-term quality of life (QOL) outcomes will be associated 
with tic suppression ability. 
A one-tailed Pearson’s correlational analysis was conducted to test for associations 
between the GTS-QOL total score and tic suppression ability (%) at T3 (follow-up). 
The GTS-QOL total score was significantly negatively correlated with tic 
suppression ability (r = -.52, large effect size, p = 0.008) indicating that a greater 
ability to suppress tics is associated with a better self-reported QOL (as measured 
by the GTS-QOL where smaller scores indicate better self-reported QOL). This 
association is depicted in Figure 4. 
 
 
Figure 4: Correlational analysis of the association between tic suppression ability 
and quality of life at follow-up 
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Hypothesis 4: Improvements on the Flanker test of attention and inhibitory 
control will be maintained at 12-month follow-up in both groups. 
A 2 x 3 RM-ANOVA test was used to analyse flanker age adjusted scaled scores. A 
mixed model design was used with group condition (CBIT and PE) as the between-
subjects factor and time (T1, T2 and T3) as the within-subjects factor. 
The assumption of sphericity was violated and the Greenhouse-Geisser correction is 
reported. There were no main effects of time (F(1.4,33.4) = 0.81, p = 0.414), group 
condition (F(1,24) = 0.04 p = 0.836) or group-time interaction (F(1.4,33.4) = 0.48, p 
= 0.558). These findings indicate that there were no observed long-term 
improvements in attention and inhibitory control in either group. 
Hypothesis 5: Children in both groups will improve on school attendance in 
the 12 months post-treatment compared with the 12 months prior to group 
treatment. 
School attendance data was analysed using a 2 X 2 mixed model RM-ANOVA with 
time (pre- and post-treatment) as the within-subjects factor and group (CBIT and 
PE) as the between-subjects factor. The CBIT group reported a change in 
attendance rates from 92.34% to 95.22%, whilst there was also an observed shift 
from 93.69% to 95.99% in the PE group. 
A main effect of time was observed (F(1,23) = 10.04, p = 0.004, p2=0.30, large 
effect size). There was no main effect of group (F(1,23) = 0.13, p = 0.723) or group-
time interaction (F(1,23) = 0.51, p = 0.484). These results indicate that children in 
both group conditions demonstrated significantly higher school attendance rates at 
post-treatment when compared to pre-treatment school attendance. Findings 
support hypothesis 5 and are displayed in Figure 5. 
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Figure 5: Main effect of time on school attendance rates8 
 
4. DISCUSSION 
4.1 MAIN FINDINGS 
This study investigated 12-month follow-up outcomes of group interventions for 
children with TS. Overall, findings offer support for the long-term efficacy of group-
based CBIT and PE treatments. 
Results highlight continued improvements in tic severity in both CBIT and PE 
participants over the follow-up period, with indication of a slightly greater 
improvement in CBIT participants. Both group participants demonstrated continued 
improvement in QOL over the follow-up period and a greater ability to suppress tics 
was associated with greater QOL. Results also indicated that children in both group 
conditions improved in school attendance. Improvements in behavioural inhibition 
                                                          
8 Y-axis compressed to clarify findings. 
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observed at T2 for CBIT participants appear not to be maintained at the 12-month 
follow-up. 
4.1.1 Tic severity 
Twelve months after group treatment, children in both group conditions maintained 
the tic severity improvements observed at post-treatment assessment. In addition, 
both groups demonstrated continued tic severity improvements. These appear to be 
predominantly driven by ongoing improvements in motor tic severity, as observed on 
the motor subscale of the YGTSS. There is a tentative suggestion of greater motor 
tic improvement amongst the CBIT group compared to the PE group, with the CBIT 
condition demonstrating a 17.2% improvement in motor tic severity across the 
follow-up period, compared to an 11.4% improvement in the PE group. This is not 
surprising given that 73% of tics chosen to be treated in the CBIT group were motor 
tics and common motor tics (e.g. eye blinks and head jerks) have been found to be 
particularly responsive to behavioural treatment (McGuire et al., 2015). This 
potential group difference in improvement during the follow-up period is in line with 
group differences observed immediately following treatment (Yates et al., 2016). 
Findings for the CBIT group in this study are comparable to previous trials, although 
on a more modest scale. In a trial comparing HRT to supportive psychotherapy in 
adults with TS, Deckersbach et al. (2006) reported a 10.9-point tic severity reduction 
between pre-treatment and six-month follow-up in the HRT condition. The present 
study found a slightly smaller reduction of 7.7 points in the behavioural treatment 
condition. It is possible that this study’s more modest findings reflect a diluting effect 
of group-based behavioural treatments compared to individual treatment. 
However, it should be noted that Deckersbach et al. offered 14 sessions of 
treatment, whilst the present study evaluated an 8-session intervention. This could 
explain the smaller reduction in tic severity. Studies by Verdellen et al. (2004) and 
113 
 
Woods et al. (2008) have also offered longer interventions, reporting treatment 
lengths of 12 and 10 sessions, respectively. Future studies aiming to replicate the 
findings of this study would benefit from increasing the number of treatment 
sessions. This would enable more confident comparisons to be made between 
group and individual interventions. 
There are no existing long-term findings pertaining to psychoeducational treatment 
for TS, meaning that present outcomes cannot be contextualised in previous 
empirical evidence. Despite this, current findings demonstrate a 5.9-point reduction 
in tic severity in the PE group, which could be considered as an indication of long-
term treatment response, in line with Storch et al. (2011)’s guideline of a 6-point 
reduction as indication of treatment response. 
Continued improvement in tic severity was not anticipated or hypothesised. Of the 
follow-up data that exists, findings have predominantly shown a stabilisation of 
treatment effects, maintained between post-treatment and follow-up assessments 
(Deckersbach et al., 2006; Wilhelm et al., 2003). 
There are several theoretical explanations for this observed effect. Firstly, it should 
be noted that thirteen participants engaged in further psychological treatment during 
the follow-up period (7 CBIT; 6 PE). Although in all cases on-going intervention was 
not directly focused on tic symptoms, it is possible that an improvement in related 
conditions, such as OCD or generalised anxiety, may positively influence tic 
symptoms. Indeed, anxiety has been found to exacerbate tic severity (Conelea & 
Woods, 2008), which suggests that alleviating anxiety may consequently contribute 
to tic severity improvement in the long-term. 
It can be theorised that two distinct therapeutic working mechanisms were 
responsible for tic improvement in each of the two groups. Children randomised to 
the CBIT group may have continued to practice and master tic suppression 
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strategies following group completion, leading to ongoing improvements. Indeed, 
significant improvements in tic suppression ability were observed for the CBIT group 
between pre-treatment and follow-up but not the PE group. 
Continued tic severity improvements observed for the PE group could be 
hypothesised as a secondary outcome of the long-term beneficial effects of 
psychoeducation on managing psychosocial symptoms such as anxiety and school 
functioning (Nussey, Pistrang and Murphy, 2014). 
Another theory is the possibility of a mutual underlying mechanism present in both 
groups and hence influencing tic severity symptoms in both conditions. One 
example of this is exposure to peer support and social normalisation of symptoms. 
Again, this could lead to a reduction in overall anxiety that could positively influence 
symptoms. Additionally, the group format may have facilitated a sharing of coping 
strategies between participants leading to subsequent symptom improvement. 
A change in evaluator between T2 and T3 does make the study vulnerable to a 
rater-effect which could have also contributed to the observed continued 
improvement in scores at T3. However, only the YGTSS (which is clinician-rated) 
was susceptible to a rater-effect. Steps were taken to minimise this by ensuring all 
three raters were trained by the same consultant clinical psychologist (TM) and 
inter-rater reliability was measured and considered acceptable. 
4.1.2 Quality of life 
Participants in CBIT and PE groups maintained QOL improvements at follow-up 
after excluding participants that had experienced a significant life event during the 
follow-up period. Furthermore, continued long-term improvements were observed for 
both groups of participants, with no significant differences between conditions. This 
continued improvement is consistent with previous research suggesting that 
psychosocial outcomes show greater improvement at six month follow-up than 
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directly following individual tic treatment, suggesting that participants may benefit 
from a consolidation period following intervention (Woods et al., 2011). 
Quality of life outcomes were found to correlate with tic suppression ability across 
the whole sample of participants, indicating that children demonstrating greater tic 
suppression ability at follow-up also showed higher levels of self-reported QOL. This 
finding supports and builds upon recent research that demonstrated a relationship 
between participants’ satisfaction with their ability to control tics and their self-
reported QOL (Matsuda et al., 2016). 
4.1.3 Neuropsychological outcomes 
Post-treatment neuropsychological outcomes indicated an initial improvement in 
attention and inhibitory control for both CBIT and PE participants, as measured by 
the Flanker test at T2 (Yates et al., 2016). This effect was not observed at follow-up 
assessment and therefore it is possible that the group interventions may produce 
short-term changes in neuropsychological functioning that are not sustained in the 
long-term. 
Improvements on neuropsychological measures have previously been demonstrated 
for both behavioural interventions and waitlist controls (Deckersbach et al., 2014) 
and it could therefore also be theorised that these observed improvements may be a 
consequence of practice effects given the short period of time between test and re-
test (~10 weeks). This theory is consistent with the findings of this study, which 
showed that originally observed improvements in inhibitory control and attention at 
post-treatment assessment (T2), were not sustained at 12 months (T3). Test-retest 
reliability data for the flanker test indicates practice effects at 21 days (ES = 0.27, p 
< 0.001) when measured with an adult sample (Weintraub et al., 2014). 
Unfortunately, reliability data from a child sample is not currently available for the 
flanker test. Currently, there are no recommended guidelines for acceptable retest 
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periods, however these practice effects could account for the apparent effects 
observed at T2. 
4.1.4 School attendance 
Participants in both conditions experienced a rise in school attendance to just above 
95% following group treatment. These findings are significant given that medical 
illness accounts for 59% of school absences in the UK (Department of Education, 
2016). Importantly, these findings also place both groups of participants in line with 
the national secondary school average of 95%, and marginally above the typical 
threshold for school attendance targets (Department of Education, 2016). 
The observed improvement in school attendance is not surprising given that both 
groups of participants also demonstrated significant improvements in tic severity 
between T1 and T3 (follow-up). As previously reported, Leckman et al. (1998) 
identified that up to 20% of children with TS may experience school-interfering tic 
severity, affecting their ability to attend school. This suggests that an improvement in 
tic severity may directly reduce some of the tic-related practical difficulties 
experienced in the classroom which could subsequently improve school attendance. 
Alternatively, children may have indirectly benefited from an improvement in tic 
severity by experiencing a reduction in teasing and bullying and an improvement in 
peer relationships at school. This could in turn lead to an increase in the child’s 
attendance. 
The group format of the interventions may to some extent simulate a classroom 
setting, with children ‘taught’ in the presence of other children. The group format 
could therefore offer specific therapeutic gains that are more readily transferable to 
a school setting. Children in the CBIT group learnt to suppress their tics in the 
presence of other children, potentially strengthening their ability to utilise this 
strategy in a classroom setting. Psychoeducation participants on the other hand, 
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may have benefitted from a perceived social acceptance and normalisation of their 
symptoms by other children whilst attending the group. These psycho-social benefits 
could in turn have carry-over effects to the child’s school environment. Future 
studies would need to directly compare school attendance outcomes of individual 
and group treatments in order to determine whether there is a unique benefit of 
group-based interventions. 
4.2 CLINICAL IMPLICATIONS 
These findings suggest that group treatment for TS can be considered a reasonable 
alternative to individual treatment where services are resource-limited. This study 
also offers specific support for the provision of group-based psychoeducation as an 
alternative to behavioural treatment, with comparable long-term outcomes. 
These findings contribute to a wider evidence base that can support clinicians and 
families to make decisions about treatment. Results indicate that group treatments 
can contribute not only to reductions in tic severity, but can also positively impact on 
a child’s school attendance and self-perceived quality of life in the long-term. These 
are important outcomes to consider when deciding on treatment and should be 
taken into consideration alongside the patient’s identified needs and treatment 
goals. 
4.3 STRENGTHS AND LIMITATIONS 
A detailed description of the strengths and limitations of the original study design 
has been reported previously (Yates et al., 2016). In brief, the strengths of this study 
lay predominantly in the single-blinded, randomised, controlled design. This design 
allowed for the robust measurement of clinical change over time in two group 
conditions that were matched for frequency, duration and clinician-contact time. 
Treatment in both groups was structured and protocol-driven to maintain treatment 
fidelity and outcome measures were scored using the same detailed scoring 
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protocols across all three time points to maintain consistency. Treatment was 
conducted by highly experienced and specialised clinicians within a specialist clinic 
setting. A gold standard clinician-rated tic severity scale (YGTSS) was used as the 
main outcome measure, and evaluator blindness were accounted for and measured. 
The study had an overall attrition rate of 15% between T1 and T3. The follow-up 
study benefitted from low attrition (3.4%) with only one participant lost between T2 
and T3. This is significantly lower than in previously reported follow-ups (Verdellen 
et al., 2004; Wilhelm et al., 2012), and may have benefitted from the use of home-
based assessments, increasing convenience for the family and reducing the burden 
of travelling to the clinic. Conducting assessments at the child’s home rather than in 
the clinic also allowed for the measurement of symptoms in an environment familiar 
to the child, increasing the ecological validity of the measures. 
The lack of an additional control group limits the conclusions that can be made from 
the findings. As previously discussed, natural remission of symptoms may have 
occurred over the course of the 12-month follow-up period. A waitlist control group 
could allow for this natural effect to be monitored and controlled for, enabling any 
treatment effects to be distinguished from natural symptom remission. 
Encouragingly, existing literature reports peak tic severity as occurring between 10-
12 years (Bloch et al., 2006; Leckman et al., 1998). It should be noted that the mean 
age at T1 and T3 assessments was 10.80 and 12.06 years, respectively, meaning 
that both time points fell within or very close to the peak severity period. This 
suggests that significant, naturally occurring tic severity reductions are unlikely to 
have occurred amongst the sample. This study did however use opportunity 
sampling as a recruitment method and it is possible that patients experiencing peak 
tic severity would be particularly inclined to participate in the study. Participants 
experiencing peak tic severity at initial assessment would be expected to experience 
some level of natural reduction in tic severity in line with the waxing and waning 
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nature of TS. Systematic consecutive sampling taken from the clinic’s referral flow in 
place of opportunity sampling may have reduced this effect. 
Follow-up assessments were conducted by a researcher not involved in the original 
study, and evaluators from the original study were not involved in any aspect of the 
administration or scoring of the follow-up assessment. The lack of evaluator 
crossover helped preserve blindness of the follow-up assessor. As previously 
reported, the assessment procedure was highly protocoled to reduce variation 
between evaluators. Furthermore, evaluators from the original study trained the 
follow-up evaluator in the assessment protocol and the same consultant clinical 
psychologist (TM) trained all three evaluators in the administration and scoring of 
the YGTSS. Inter-rater reliability data between the original study and the follow-up 
assessment would help account for any rater-bias, however it was not available for 
this study. 
The relatively small sample size meant that the study was underpowered for the 
detection of smaller effects, and a larger RCT would be recommended in order to 
replicate these findings and explore further predictors of long-term treatment 
response that this study was not sufficiently powered to investigate. 
4.4 FUTURE RESEARCH 
Given the small sample size of the current study, a larger RCT would be needed to 
replicate findings. A multi-site, community-based study would also be informative.  
Future studies would benefit from a waitlist control in order to account for natural 
symptom change, or a ‘minimal treatment’ condition to account for the potential 
placebo effect of perceived support from a specialist clinic. It would be interesting to 
include an alternative control group consisting of individually administered treatment 
in order to directly measure the effect of a group-based format. This would help 
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determine whether there is in fact presiding long-term benefits of group treatment 
over individual treatment, as indicated in the findings from this study. 
Given that both the CBIT and PE groups demonstrated significant symptom 
improvement in both the short-term and the long-term, further investigation into the 
precise mechanisms of change in these respective treatments (and to determine 
whether these therapeutic mechanisms are mutual or distinguishable between the 
two approaches) would be important for the future design and development of TS 
interventions. 
4.5 CONCLUSION 
In a sample of children with diagnosed TS, group-based interventions offered 
sustained benefits to tic severity, quality of life and school attendance. No long-term 
benefits were observed on neuropsychological measures. These results support the 
implementation of CBIT and PE group treatments for children with TS. Continued 
improvement over the follow-up period was observed in both group conditions 
suggesting that a mutual therapeutic mechanism may underlie long-term symptom 
improvements, although research is required to establish the specific treatment 
components offering the greatest long-term therapeutic benefit. Future studies 
would benefit from a larger sample and alternative control groups. 
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1. INTRODUCTION 
This critical appraisal focuses on three key aspects of the research study. Firstly, it 
considers the process of conducting a follow-up study as part of a larger trial, 
appraising the unique advantages and disadvantages that this offered. Secondly, 
further strengths and limitations of the study’s methodology are explored. Finally, the 
appraisal reflects on the experience of working with children with a 
neurodevelopmental disorder. 
2. CONDUCTING A FOLLOW-UP STUDY AS PART OF A LARGER TRIAL 
This follow-up study was part of a wider randomised controlled trial (RCT). My role 
was to assess participants at 12 months post-treatment in order to evaluate the 
long-term outcomes of the interventions that were trialled. 
2.1 RECRUITMENT 
Conducting a follow up study as part of a wider project had many unique 
advantages as well as some associated difficulties. One advantage was that the 
participant sample was pre-determined and therefore there was no need to identify 
new participants. This however also meant that the maximum follow-up study 
sample size was limited to the sample size of the original trial. All participants had 
previously agreed to follow-up participation, however, they were also free to drop out 
at any time during the follow-up period. Participants from the original study therefore 
needed to be ‘re-recruited’. Given that a significant amount of time had passed 
between the original recruitment phase and the follow-up assessment, there was 
potential for high levels of attrition. Previous studies of behavioural treatment for 
Tourette syndrome (TS) have reported attrition rates of 11%-28% across follow-up 
periods of shorter length (Himle et al., 2012; Piacentini et al., 2010; Wilhelm et al., 
2003) therefore a dropout rate of at least 10% was anticipated for this study. 
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A small sample size had the potential to significantly under power the study and this 
was identified as a potential issue in the early stages of evaluating the study’s 
feasibility. In order to help minimise attrition, it was decided that I would make 
contact with each of the families by letter a few months before recruitment began. A 
brief letter was sent out thanking the families for participating in the original trial, 
reminding them about the follow-up study, introducing myself and informing them 
that I would be in contact again in a couple of months’ time. A second letter was 
then sent out a few months later followed by a telephone call. This multi-stage 
contact process aimed to facilitate recruitment and increase participant uptake. 
The follow-up study did in fact suffer minimal attrition with only one participant 
considered a ‘drop-out’ between T2 and T3. The low attrition rate was a key success 
for the study, helping to not only power the study but also highlighting the feasibility 
of long-term follow-up research. On reflection, there are a number of reasons, aside 
from the potential impact of the frequent correspondence, which could help to 
explain the low dropout rate. Firstly, assessments were conducted at participants’ 
homes, unlike previous follow up studies (Deckersbach, Rauch, Buhlmann, & 
Wilhelm, 2006; Wilhelm et al., 2012). Given that the clinic is a national centre, some 
of the participants lived relatively far away, meaning that travel time could be up to 3 
hours when visiting a family to administer the assessment. Taking part in the follow-
up therefore offered families an opportunity to make contact with the clinic whilst 
eliminating the burden of travel. Secondly, the reputation of the clinic may have 
influenced the rate of participant engagement. The clinic is renowned for its work 
with children with tics and many families had gone through a long referral process 
before being referred to the clinic, potentially increasing their appreciation for the 
support offered by the clinic and influencing their desire to maintain involvement. It 
also became evident that the group sessions had helped to facilitate links between 
the families, with some parents reporting that since taking part in the groups, their 
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children had maintained contact with other participants. It is possible that the group 
format of the interventions had helped develop a sense of unity and cohesion 
amongst some of the participants, which in turn could have positively influenced 
their continued willingness to participate in the research. 
2.2 TIMING 
Alongside the issue of attrition, the follow-up study also carried with it an element of 
time pressure. The assessment was planned for 12 months post-treatment, meaning 
that there was a significant amount of pressure resting on the completion of ethical 
approval amendments and the recruitment stage in order to ensure the appropriate 
timing of the assessments for each of the participants. On reflection, I felt that these 
added pressures were well balanced with advantages that the study held such as 
not having to go through the full process of gaining ethical approval. The study only 
required a major amendment to the original ethical approval and this substantially 
reduced the time spent on ethics, making it possible to begin recruitment in good 
time. All but one of the participants were assessed within 30 days of the 12-month 
mark. 
2.3 STUDY DESIGN 
Joining an existing research trial required me to quickly grasp the study’s 
procedures and existing methodology whilst also ensuring that I understood the 
theoretical rationales underpinning the existing methodology. 
The design of the follow-up assessment needed to be in line with the original 
assessment methodology in order to ensure consistency across the trial and both of 
the previous trainees devoted time to fully handing over the research. This support 
early on in the study was invaluable and without it, it would have been difficult to 
ensure the reliability of the assessment. 
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This need for consistency did however limit the flexibility of the follow-up study 
design. Measures used were largely limited to those that had previously been 
administered and for which there were previous sets of outcomes in order for 
comparisons to be made. This, to some extent, shaped the remit of the present 
study. An exception to this was the additional inclusion of school attendance data 
which was obtained post-hoc for the year prior to group involvement and for one full 
academic year post-treatment. This outcome measure contributed an additional, 
unique aspect to the study. 
There were certain features of the study design that I would have liked to have 
adapted, such as including a third treatment condition consisting of individual 
treatment in order to directly compare outcomes between group and individual 
therapy. The results of the study demonstrated good outcomes for both group 
treatments, offering potential support for the theory that the psychosocial benefits of 
a group-format may have contributed to symptom improvement in participants. 
Including an individual treatment condition would further contribute to our theoretical 
understanding of these findings. 
Despite the limitations of joining an established study, it is undoubtable that 
combining research efforts with two other trainees enabled the development of a 
larger, more robust research project. This enabled access to a relatively large 
amount of data, affording me a good amount of flexibility in hypothesis development 
and outcome analysis. It also offered the opportunity to contribute to a high quality, 
longitudinal, RCT: a study design that would have been unrealistic to develop and 
execute as an individual project. 
3. FURTHER STRENGTHS AND LIMITATIONS OF THE STUDY 
3.1 DESIGN 
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A randomised controlled design facilitated the experimental comparison of two 
interventions matched for treatment length and clinician contact time. However, the 
lack of a waiting list or individual treatment control group limited the conclusions that 
could be made from this study. A waiting list control group would have accounted for 
natural symptom fluctuation or remission over the course of the follow-up period, 
enabling natural fluctuation in symptoms to be distinguished from treatment effects 
over time. This is particularly important when evaluating long-term effects of 
treatment as longer follow-up periods are more likely to capture some element of 
symptom fluctuation. These adaptations would be useful to consider in future 
studies. 
The distinguishable nature of the therapeutic components of each intervention 
meant that it was not possible to blind participants to group allocation. Both groups 
were however described as active treatments for TS with neither pitched as more 
effective than the other when recruiting participants. Despite this, participants may 
have been susceptible to expectancy effects that could have influenced findings. 
Occasionally, during home visits, participants would unintentionally discuss their tics 
in such a way that indicated their group allocation to the assessor. An example of 
this is when a child would use the word ‘suppress’ when describing tic management. 
This would suggest that they had taken part in the CBIT group, and therefore 
potentially compromise assessor blindness. This may also explain the larger 
proportion of assessor unblinding detected in the CBIT condition. 
3.2 OUTCOME MEASURES 
The study included both subjective and objective measures of tic severity. The 
primary outcome measure consisted of the Yale Global Tic Severity Scale (YGTSS): 
a clinician-administered, gold standard outcome measure. This scale enabled both 
children and their parents to be interviewed together, offering multiple perspectives 
139 
 
and information on the variety and frequency of the child’s tics. This was particularly 
important given that on multiple occasions parents were able to identify tics that the 
child did not seem aware of and therefore would not have reported if interviewed 
alone. Indeed, self-report assessments of tic severity have been shown to be 
inaccurate, with most individuals underestimating the severity of their symptoms 
(Pappert, Goetz, Louis, Blasucci & Leurgans, 2003). 
Video observations of tic expression and tic suppression were also conducted for 
each participant, however the setup of the video recording meant that observation 
was limited to the head and upper torso area and lower body motor tics were 
therefore not recorded. This was a significant limitation of the measure that affected 
its reliability. Furthermore, despite efforts made to match the emotional content of 
the T3 Simpsons episode to the content of the episodes used at T1 and T2, 
episodes will have inherently varied from one another. Contextual factors such as 
stressful and anxiety-inducing events have been found to worsen tics (Conelea & 
Woods, 2008) and therefore the varying emotional content of the episodes at each 
time point may have confounded tic frequency outcomes. For this reason, it was 
decided that video recordings would be used to calculate a measure of tic 
suppression ability only, computed by comparing tic frequency during a period of 
free ticcing, against tic frequency during a period of active tic suppression. This 
approach enabled episode content to be controlled for and provided a suppression 
ability measure whilst controlling for any tics that were unobservable. 
3.3 SETTING 
Home-based follow-up assessments reduced burden on families and contributed to 
the ecological validity of the study, enabling the assessment of tic severity and tic-
associated symptoms to take place in an environment familiar to the child. 
Nonetheless, conducting outcome measurement in family homes meant that the 
testing environment was not strictly controlled for. All families were informed in 
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advance that the assessment would need to take place in a quiet room with a table 
and chair in order to enable the participant to concentrate on the various tasks and 
questionnaires. It is of course difficult to eliminate all distraction and disruption in a 
naturalistic setting. The neuropsychological measures, which were timed to the 
accuracy of a centisecond, were most vulnerable to disruption. This variable partially 
obviated by the fact that participants acted as their own controls across time points, 
therefore controlling for the testing environment to some extent. Despite this, the 
presence of siblings and other distractions will have influenced concentration levels 
and the child’s ability to focus. Efforts were made to manage these distractions 
through the use of regular breaks and pauses in testing where necessary and 
possible.  
4. WORKING WITH CHILDREN WITH TOURETTE SYNDROME 
An interest in developmental neuropsychology and an affinity for working with 
children drew me to this study. However, prior to undertaking this research I had 
little direct experience of tic disorders and TS and much of my knowledge about this 
condition was influenced by popular media’s portrayal of the condition. Tourette 
syndrome is a disorder that garners a relatively large amount of media attention 
relative to other conditions. This is predominantly due to the syndrome’s often 
conspicuous symptoms which can mimic intentional behaviours. There is a common 
misconception that TS is primarily characterised by vocal tics, and more specifically, 
coprolalia. In fact, I quickly grew to understand the nature of the disorder and the 
significance of motor tics. It was primarily motor tics that children cited as 
bothersome, often interrupting everyday tasks such as handwriting or sports 
activities, and therefore becoming a significant source of frustration. 
I witnessed a broad range of family approaches, coping strategies and attitudes to 
the condition, ranging from humour, to those that were experiencing a significant 
family-wide emotional struggle with the disorder. It was of course upsetting to hear 
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of the many struggles that families had experienced and to witness clear frustration 
and dismay at times, however this range of responses also served an important 
reminder of the different ways that a disorder can impact the wider family and the 
importance of not making assumptions or generalisations about coping and 
resilience. 
Whilst conducting follow-up assessments, I was in the privileged position to be able 
to witness many inspiring accounts of recovery. The evident gratitude from families, 
alongside the first-hand experience that I gained from home visits, instilled a sense 
of hope and optimism for clinical effectiveness in the area of TS. On the whole, this 
was hugely encouraging and became a motivating factor for my research, having 
seen the benefits attributed to the approaches that I was investigating. 
I occasionally came across children who appeared to be experiencing a peak in their 
tic severity. With so many stories of recovery and symptom improvement, these 
sporadic cases were particularly conspicuous in their severity. One child stood out in 
particular due to the high frequency and complexity of their tics which presented not 
unlike a seizure. This seizure-like presentation was particularly difficult to witness 
throughout the video observation, during which the intensity of the bodily tics made it 
difficult for the child to remain in his seat, and most of his attention was focused on 
trying to stabilise himself rather than being able to utilise the ‘break’ in assessment 
to watch the Simpsons episode. Moments like these were upsetting and made me 
question the usefulness of the assessment. These moments demonstrated the 
tension in research ethics between deontological and utilitarian factors and made 
me wonder whether in this case, the assessment process was adding unnecessary 
pressure to a child already experiencing significant burden from his symptoms. 
Conducting home-based assessments offered an opportunity to gain a broader 
picture of what it is like for a child and their family living with the symptoms of TS. 
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This experience contributed to a richer understanding of the wide-reaching impact of 
TS and the systemic impact that it can have. 
5. SUMMARY  
Conducting a follow-up study as part of a wider RCT presented both specific 
difficulties as well as unique advantages, which overall I believe were adequately 
balanced. Reflecting on the limitations of the current study has helped to identify 
potential changes that could be made to future studies. 
Working with children with TS and their families offered a unique insight into the 
daily highs and lows of living with TS and it was a privilege to witness the admirable 
resilience of these families. Reflecting on this research journey as a whole has 
highlighted not only the extent of the knowledge that I have gained in this research 
area, but also how my understanding of both the research topic and the empirical 
process has developed and evolved over time. This study has given me an 
appreciation for the practice of conducting high quality empirical research and has 
strengthened my interest in conducting research in the future. 
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Appendix A: Outline of trainee contributions to the wider project 
 
The original study was designed and carried out by two trainee clinical psychologists 
(KE and RY) as a joint research project. Ethical approval was at that time submitted 
for a follow-up study to be conducted 12 months post-treatment. 
The clinical team at the tic clinic adapted the treatment protocols and ran the 
groups. KE and RY recruited the participants, designed the assessment protocol 
which was adapted for use in the present study, and carried out assessments at T1 
(pre-treatment) and T2 (post-treatment). Data from these two time points contributed 
to the present study’s longitudinal data set.  
The follow-up study required a major amendment to ethical approval and 
adaptations to the assessment protocol. Additional outcome measures (tic 
suppression ability and school attendance rates) were also added to the study’s 
design. Separate documents (consent forms, questionnaires, letters and information 
sheets) were developed for the follow-up study although these were adapted from 
and in line with the original study’s documentation in order to maintain consistency.  
KE and RY’S involvement in the current study was limited to the provision of 
assessment protocol training. The author conducted all follow-up assessments, 
video coding, scoring, data entry, analysis and write up, independently. The external 
supervisor re-coded 10% of YGTSS interviews to test for inter-rater reliability. 
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Appendix B: Further details of ethical considerations 
Home-based assessments were conducted in accordance with the hospital’s Lone 
Working Policy and parents were asked to remain at home at all times during the 
assessment. The author made contact with the principal investigator upon 
completion of each assessment. 
All confidential data was securely stored in accordance with the NHS Code of 
Confidentiality. Each participant was allocated a study ID number that was used on 
all paper-based documentation and electronic databases. Electronic databases 
were password protected and confidential paper-based documentation was stored in 
a locked office at the hospital. Electronic data collected during the home 
assessment was stored on the laptop within an encrypted hard-drive and transferred 
to the main secure electronic database and encrypted hard-drive at the hospital 
following the assessment. 
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Appendix C: Ethical approval letter from London Queen Square Research Ethics 
Committee 
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Appendix D: Ethical approval email from the hospital’s research and development 
department 
 
Dear Dr  
  
PROJECT TITLE Randomised Pilot Study Evaluating Two Group Therapies for TS 
- Group work for children with Tourette Syndrome (TS): A 
randomised pilot study to evaluate the efficacy of a tic-specific 
behavioural intervention versus psycho-education in improving 
tic severity, quality of life and neuropsychological functioning 
 
REC Reference 13/LO/0511 
R&D Reference 13BS04 
Amendment 
Number 
1 
Amendment 
Date 
18th September 2014 
Date of REC 
approval 
1st October 2014 
 
 
  
    
Notification of host site amendment approval 
                                
  
Thank you for your correspondence with regards to the amendment(s) for the above 
named study. The Joint Research & Development Office can confirm that this/these 
amendment(s) do not affect current local approval for the study. 
  
Thank you for keeping us informed. 
  
Yours Sincerely 
  
  
Dr  
Research Management and Governance Officer 
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Joint Research and Development Office 
 
 
Tel:    
Fax:   
Email:  
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Appendix E: Additional details of the group interventions 
 
Session Key elements 
Psycho-education CBIT 
1  Introduction to aims 
and content of the group 
 Establish and agree 
‘rules’ for the group 
 Define the condition 
 
 Introduction to aims and content of the 
group 
 Establish and agree ‘rules’ for the group 
 Define the condition 
 Introduce HRT 
2  Self esteem 
 Personal strengths 
 6 month goals 
 Tic awareness 
 Identifying triggers for tic onset 
3  TS and school 
 Bullying 
 Tic awareness 
 Moving on to treatment 
 Selecting the first tic 
4  Noticing everyday 
emotions 
 Noticing anger 
 Relaxation exercise 
 Tic awareness 
 Tic detection 
 Choosing competing response for tic 1 
 Relaxation exercise 
5  Anxiety 
 OCD (identifying 
obsessional thoughts and 
compulsions) 
 Relaxation exercise 
 Introduction to ERP 
and habituation 
 Using competing response on tic 1 
6  ADHD (the see-saw) 
 
 Selecting tic 2 
 Recognising tic 2 
 Practicing competing response on tic 2 
7  Problem solving 
situations at home 
 Improving attention 
 Using competing response on tic 3 
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8  Quiz 
 Certificates 
 Practicing competing response on tics 1, 2 
and 3 
 Identifying potential future situations that 
may trigger tics 
 Getting help in the future 
 Certificates 
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Appendix F: Assessment protocol 
 
Beforehand 
 Tell TM where you will be and time of visit.  
 Take contact details for TM  
 Agree a time after which you will speak. 
 Copy demographic information into new empty Excel spreadsheet. Save on F drive 
under ppt number. 
 Make sure you know if they’ve had a WISC in the last 6 months and input data if so. 
 Set up new login for that child on the assessment centre and add password and login 
to the spreadsheet 
 Book travel. Bring address and contact details and give this information to TM 
 
If contacting families from own phone change settings to hide phone number: 
Either dial 141 before the number or (if this doesn’t work) change mobile phone 
settings (Menu – Settings-Call-Additional settings-Caller ID) 
Equipment List (bold = things to replace each time) 
 ID badge 
 Tickets and travel information 
 Address of family; name, date of birth and age of child 
 Participant number for child 
 Laptop + power cable 
 Demographic info sheet 
 Three-way plug adaptor 
 Monitor, connector cable + power cable 
 Keyboard, mouse, speakers 
 Pegboard, pegs and spares 
 Stopwatch 
 Pencil without rubber x 2 
 Little reward 
 Bluetak 
 Internet dongle 
 DVD for watching during obs 
 Full assessment protocol 
 Questionnaire pack for right age range (i.e. 13/ under 13 based on age they were at 
first assessment): 
o YGTSS form 
o Tourette Syndrome Questionnaire 
o PUTs 
o PEDs-QL (version different if aged 13) 
o GTS-QOL (version different if aged 13) 
 Parent questionnaire pack: 
o Rage attacks questionnaire 
o SNAP-IV 26 
o SDQ 
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Equipment for Scoring 
 Ruler, Clicker counter 
 
Introduction 
Introductions 
Outline of assessment – show visual timetable 
Reminder not to disclose group allocation if possible 
Collect parent consent forms 
Give parent questionnaires   
Request internet password      (2 mins) 
 
Go over T3 questions from demographic sheet: 
 
o Since the end of the group treatment have there been any changes in medication?  
o Since the end of the group treatment have there been any significant or stressful 
life events?  
o Contact details still correct?  
o Would they like to be contacted with regards to the findings of the FU study?  
 
Initial questionnaires 
 
1. GTS-QLS (NB: different questionnaire if age 13) (5 mins)  
 
2. TS Visual Analogue Scale      (5 mins)  
 
Allow them to complete these on paper during the set up the computer equipment 
etc. 
 
Neuropsychological Measures 
 
3. Dimensional Card Sort       (4 mins)  
Only index finger 
 
4. Flanker Inhibitory Control      (3 mins)  
Only index finger 
 
5. Motor Dexterity task (Pegboard)     (4 mins)  
Test dominant hand first. 
Position board horizontally with round container next to hand being tested, use 
bluetak to pin down 
Demonstrate task 
Practice and test trials for each hand 
Other hand to be kept by side 
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Lay hand on table until told to go. 3-2-1 go… 
 
Start the stop-watch as soon as the person touches the first peg 
Stop the stopwatch as soon as the last peg hits the container. 
[Record time with milliseconds for dominant and non-dominant hand)  
Reposition the unit so round container is next to non-dominant hand. Repeat test. 
 
6. PEDs-QL (NB: different questionnaire if age 13)  (5 mins)  
Enter data directly onto computer as they complete the paper form 
Can put equipment away at this stage if necessary or convenient 
 
7. PUTS         (5 mins)  
Enter data directly onto computer as they complete the paper form 
 
8. Direct Obs while watching video     (20 mins) 
Set up video and camera 
“Now I’m going to film you, just to get a bit of a sense of what you’re like. I’ll put 
this video on so you can have something to watch and don’t worry about the 
camera. It can be a bit of a break for you as well.” 
Say “Simpsons 1”.  
Start stop watch. 
 
At 15 minute, say “stop”. 
Label video Ppt number and assessment date and NS (non-supp) or TS (tic 
suppression) 
 
“Now I’d like you to watch for another 5 minutes, but this time try your best to 
hold your tics in as much as you can for 5 minutes. After that I’m going to give you 
this toy as a reward.” 
 
Then say “Simpsons 2”. Start stopwatch. 
Say “stop” after 5 minutes and stop video. 
Label second video (see above) 
Give small reward. 
 
While child watches the video, check their questionnaire filled in on paper for any 
missing items or unclear responses. Score Visual Analogue scale. 
 
9. YGTSS         (30 mins) 
Video this (parent and child) if this is one of the first 10% for inter-rater reliability. 
 
“Now I’d like to ask you both a bit more about the tics X has had in the last week.” 
Make sure they understand about: 
 Sound tics 
 Movement tics (can affect any part of the body, can give e.g.s if necessary) 
 Sometimes might have several that happen in a sequence 
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 Tic signal – urge and feeling better afterwards (like the urge to scratch an itch) 
 
“I’ll start by asking you about your movement tics.” 
Ask intro questions about age of onset etc 
“In the last week have you, or have other people noticed any eye blinking tics?” 
Then go through e.g.s 
 
Point out things you think are tics and check if they are (do they get tic signal? Is it 
unpleasant? How do you feel after the tic? Does it happen in different places?) 
Make sure to differentiate between hyperactivity and tics 
 
“Now let’s move on to your sound tics. Again, just thinking about the last week, 
have you, or have other people noticed any coughing tics?” 
All specific e.g.s 
 
“Now I’ve just got some more general questions about your tics”. 
 
FREQUENCY 
 “How often did your tics happen during the last week?” 
Follow-up questions 
o Do you have at least one motor tic every day? 
o How about every hour, when awake on average? 
o How about every five minutes? 
o Do they occur in different places? 
o What’s the longest time you’ve gone without ticcing in the last week? 
 
Look out for 
If the reported frequency varies from what you observe ask about the discrepancy 
It is not uncommon to tic more/less during discussion of tics 
 
INTENSITY 
 “How forceful or strong are your tics?” 
o Do they feel like they are bursting out of you really powerfully? 
o How noticeable are your tics because of their intensity? 
o You can ask how much others notice the tics (aside from family members 
and adults who know the child well) 
o Use your own observation 
o How exaggerated are the tics? Do they turn heads in public? 
o Does it lead to pain/ wounds? 
o Do you get scared of the tics? Would you turn your head? Higher scores 
then! If you doubt if someone coughs because of tics or because of 
having a cold, score lower.  
 
COMPLEXITY 
How involved or orchestrated are the tics? – for us to code but ask more questions 
if necessary to clarify. 
Follow-up questions: 
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If necessary ask about how hard they are to camouflage/how much they stand out 
due to: 
o Duration 
o Bizarre or obscene character 
o Inappropriateness 
o Unusual nature 
 
INTERFERENCE 
“How do tics get in the way when you’re trying to do things? Like speaking or 
playing or doing things at school or at home?” 
 
 
IMPAIRMENT 
“How much do tics affect your life? Are the tics stopping you from doing 
anything? Are you still able to feel good about all the great things you do?” 
 
Queries 
How do tic affect your: 
o Self-esteem/mood 
o Enjoyment of things 
o School, grades 
o Relationships with friends, family  
o Social acceptance, involvement, avoidance 
 
10. Check over any items which were missing from the child questionnaires 
completed on paper 
 
11. Collect and check parent questionnaires (check over any missing items) 
 
Save spreadsheet 
Dismount the F drive 
 
After visit 
Enter data for: 
 GTS-QoL 
 Tourette Syndrome Questionnaire 
 Parent questionnaires (SNAP-IV; Rage attacks questionnaire; SDQ) 
 Score video – non-suppression and suppression. Enter data into spreadsheet. 
 Get NIH data and add to Excel 
 
 Contact participant’s school to request school attendance for last two years 
 Double check all data entered and no remaining red cells anywhere 
 If there are any red cells, make a note of why and delete the cell in the final entry data 
so that the cell is empty and will therefore register as “system missing” in SPSS 
 
When next at GOSH -  
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Make sure participant number is correct. Then copy final data line from last tab of excel 
spreadsheet into the main SPSS file. 
Copy the video onto hard-drive which is kept in office (DS has password) 
Put questionnaires in TM’s office. 
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Appendix G: Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989) 
 
 
 
 
 
 
 
 
 
 
 
[REMOVED FOR COPYRIGHT REASONS] 
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Appendix H: Further details of ‘The Simpsons’ episode selection process 
Episodes were carefully reviewed by researchers from the original study (KE and RY) to ensure that their content was age-appropriate. Four 
age-appropriate episodes were then rated for emotional factors that have been found to influence tic expression (Conelea and Woods, 2008). 
Ratings were provided by a 14-year old girl not otherwise involved in the study. Ratings for each video were then totalled. Video 1 was selected 
for use at T1. Ratings for the remaining 3 videos were then compared to video 1. Differences in ratings were calculated to establish similarity of 
videos. Video 2 was used at T2 and video 3 was selected for use at T3 based on similarity of ratings. 
Video 
 
Episode name 
 
Rating Total difference in 
ratings compared to 
video 1 
Anxiety-provoking Boring Relaxing Stimulating Upsetting Frightening 
1 “Homer Simpson, This is your 
Wife” 
Season 17, Episode 15 
1 4 7 5 0 0 0 
2 “Mr Lisa Goes to Washington” 
Season 3, episode 2 
2 4 6 7 2 0 6 
3 “Lemon of Troy” 
Season 6. Episode 24 
3 6 4 6 0 2 10 
4 “Bart Vs Australia” 
Season 6, Episode 16 
5 3 3 4 2 4 16 
1
6
1
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Appendix I: The English translation of the Gilles de la Tourette Syndrome-Quality of 
Life Scale for children and adolescents (C&A-GTS-QOL; Cavanna et al., 2013) 
 
 
 
 
 
 
 
 
 
 
 
[REMOVED FOR COPYRIGHT REASONS] 
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Appendix J: Additional information questionnaire 
 
 
 
Identification Number_______ 
 
 
ADDITIONAL INFORMATION 
 
 
 
 
1. Since our last visit (1 year ago), have there been any changes in 
medication? If yes, please state what the change is and please include any 
information about increases or decreases in dosage. 
 
___________________________________________________________________ 
2. Since our last visit (1 year ago), have there been any significant or stressful 
life events? 
___________________________________________________________________
___________________________________________________________________ 
 
3. Since our last visit (1 year ago), has your child had any further psychological 
treatment (either from Great Ormond Street Hospital or another service)? If 
yes, please elaborate on type of treatment and number of sessions. 
___________________________________________________________________
___________________________________________________________________ 
 
 
Thank you for completing this questionnaire. 
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Appendix K: Invitation letter 
 
 
 
[Name] 
[Address] 
 
[Date] 
Dear [Name], 
Earlier this summer you will have received a letter from us providing you with an 
update about the research study that you took park in at the Tourette Syndrome Clinic 
at . The letter was also hopefully a reminder about the 
planned 12-month follow-up to this research that was mentioned to you and discussed 
at your last home visit. I am now writing again to formally invite you and your child to 
the 12-month follow-up assessment. 
Alongside this letter you will find an information sheet that outlines our reasons for 
conducting a follow-up assessment as well as information about what the follow-up 
assessment involves and what to expect if you agree to participate. There is also a 
children’s version of the information sheet included which we would be grateful if you 
can discuss with your child. 
If you and your child are happy with the information provided and would like to 
continue participating in this study, or would like to know more, please contact Dr  
 on . Further details are also provided on the enclosed 
information sheets. 
If we do not hear from you, we will contact you by telephone in the next few weeks to 
check you have received this information and to discuss any queries you may have. 
If you agree to participate in the follow-up, we will aim to arrange a suitable time to 
visit your home for the follow-up assessment. 
 
Many thanks for taking the time to read the enclosed information. 
 
Yours sincerely, 
Signature 
 
Dr  
Consultant Clinical Psychologist  
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Appendix L: Parent information sheet 
 
 
 
 
 
 
 
 
 
 
Information about the project 
 
Project title: Follow-up to a Randomised pilot study evaluating two group 
therapies for Tourette Syndrome  
 
We work at the Tourette syndrome Clinic at  
. We would like to invite you and your child to take part in the follow-up of 
a research study that you have been involved in. Before you decide if you would 
like to take part, it is important for you to understand why the follow-up research 
is being done and what it will involve. Please read through the following 
information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take your time to 
decide whether or not you wish to take part. Participation would involve a member 
of the research team visiting your home at your convenience to carry out an 
assessment to evaluate whether the group therapy that your child attended at 
 has been effective in the long-term (1 year on). 
What is the purpose of the study? 
This follow-up study is interested in the long-term effects of group based 
psychological therapy for Tourette Syndrome and other chronic tic disorders. As 
you probably know, the symptoms of these disorders, including tics themselves, 
can impact greatly on the quality of life of those who experience them. This can 
be either directly, in terms of physical discomfort associated with the tics 
themselves, or indirectly, as a result of factors such as the reactions of other 
people or by making it difficult to concentrate on school work. It is therefore very 
important that we find effective means of treating the symptoms. 
 
Why have my child and I been asked to help? 
We are inviting all families who initially consented to taking part in this research 
study and attended group treatment at  as part of the study, to take part in 
a follow-up assessment which aims to identify any long-term effects of group 
treatment, one year on. 
 
Do I have to take part? 
No. Taking part in this follow-up study is entirely voluntary. If you decide not to 
take part, you do not have to give a reason, no one will be upset and the standard 
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of care your child receives will not be affected. If you do decide to take part, you 
can still withdraw at any time, without giving a reason. 
What will my child and I be asked to do if we take part? 
We will telephone you to arrange a home visit to carry out the reassessment.  
The follow-up assessment would be very similar to the initial assessment 
your child took part in shortly before the group treatment started. During the visit, 
we would complete some puzzles, tasks and questionnaires with your child. We 
expect that the tasks would take about 2 hours and 50 minutes, including rest 
breaks. During this time, your child would also spend 20 minutes watching a DVD 
while we video them. For the final five minutes of this section, we would ask your 
child to reduce their tics as much as they are able. We would also ask you as 
parents and carers to complete some additional questionnaires prior to this 
assessment. 
As part of this study we would also like to consider how your child’s school 
attendance might have been affected by their symptoms in order to help us get a 
fuller picture of the effects of their tic disorder. In order to do so, with your consent 
we would speak to your child’s school to obtain a % attendance rate during the 
past two years. If you have any questions about this, please do not hesitate to call 
us to discuss or alternatively we can answer any questions when we contact you 
in the next few weeks. 
 
Is there anything to be worried about if my child and I take part? 
There are no specific risks from taking part in the follow-up study. If your child gets 
tired when we are doing the tasks and puzzles then they will be able to take 
breaks.  
It is possible that thinking about their life and the effect of having a chronic 
tic disorder could be upsetting for your child. If the questionnaires do cause any 
distress, I would ask that you let us know so that we can offer support and think 
about what further help is needed.  
How will the information help people? 
When the follow-up study has finished we will write to you to let you know what 
we found out about the long-term effects of the groups. We hope this study will 
help us find out if and how group therapies are useful for children with tic disorders. 
 
Will my child’s usual treatment be affected by taking part? 
If your child is currently receiving treatment at , they 
would continue to be seen as usual. Any school liaison work, or medication, would 
continue as normal and be unaffected by participation in the follow-up 
assessment. 
 
Who will know that my child and I are taking part in the study? 
 
All information that is collected about your child during the course of the study will 
be kept strictly confidential. We would keep your and your child’s name, address 
and results from the puzzles and questionnaires secret. We would also keep all 
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paperwork in a safe place. After we have watched the videos of your child, in order 
to count their tics, the videos will be permanently deleted. We would write about 
the study but no names would be used or any information that would show it was 
your child. If you agreed then we would write to your GP to let them know you are 
taking part in the follow-up study. We would also liaise with your child’s school to 
obtain a school attendance record. 
What will happen to the results of the study? 
The results will not be known until the 12-month follow-up data is collected for 
everyone taking part in the study. We hope to complete data collection and 
outcome analysis by mid-2015. The results may appear in professional 
publications and meetings and as part of a doctoral university assignment, but 
neither you, nor your child, would be recognisable from any transcription. We will 
also write to you at the end of the study with a brief summary of what we found 
out. We hope to hold a general feedback session once the study is complete, 
which you will be invited to.  
Who has organised and approved the research? 
 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 
reviewed and approved by the London Queen Square Research Ethics 
Committee. Their contact details are provided below. The research is being 
sponsored by l.  
 
Who is funding the research? 
 
Funding for the study has been provided from two sources. These are, University 
College London and the Tourette Action, UK (the National Charity for Tourette 
syndrome).  
 
What if something goes wrong? 
 
This study is indemnified under the Clinical Negligence Scheme for NHS Trusts, 
which provides cover for negligent harm. If you have a concern about any aspect 
of this study, you should ask to speak to the researchers who will do their best to 
answer your questions. If you remain unhappy and wish to complain formally, you 
can do this via the Patient Advice and Liaison Service at  
: 
 
 Patient Advice and Liaison Service (PALS): 
PALS will help and advise on any issue related to your hospital experience. 
Email:  – Telephone:  
 
What do I do now? 
Thank you for reading this information. If you and your child are interested in taking 
part in the follow-up study, please contact Dr  (Tel: ) to 
hear more. If we do not hear from you, we will contact you by phone during 
October 2014 to answer any questions you may have and to see if you are 
interested in taking part.  
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Who do I speak to if I have further questions or worries? 
 
Contact:    
 
Address:  
 
  
  
  
  
 
 
Email:      
 
Tel:          
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Appendix M: Child information sheet 
 
 
 
 
 
 
 
 
 
Information about the project 
 
Project title: Follow-up to a Randomised pilot study evaluating two 
group therapies for Tourette Syndrome  
 
We work at . We are asking you and your 
parents to take part in the follow-up to a project you were involved in just 
under a year ago. This leaflet will remind you about the project you took 
part in, and tell you about the follow-up. We hope you can read about the 
project with someone in your family. Please ask us if you have any 
questions. Take your time to decide whether or not you want to take part. 
 
What is this project and why are we doing it? 
This study is interested in whether new therapies can have long-term 
effects for children with tic disorders. We would like to find out if the group 
treatment you attended just under a year ago has helped you in your life or 
made your difficulties easier to cope with over the past 12 months. 
 We would also like to find out whether you have found it easier to 
attend school since completing the group treatment. We would get this 
information by contacting your school directly. 
 
Why have I been asked to take part? 
We are asking all children and young people who attended group treatment 
at  and were involved in the original study, to take part in this follow-
up study. 
After you finished the group treatment you were visited by one of our 
research team members when you would have completed some puzzles, 
tasks and questionnaires. We would now like to visit you at home once 
more, to see if there have been any changes over the past 12 months. 
 
Do I have to take part? 
 
No, you do not have to take part. If you decide not to take part in this follow-
up study, you do not have to give a reason and no one will be upset. You 
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can change your mind at any time. You can stop being in the study even if 
you said yes at the beginning. 
 
Will taking part help me? 
We will evaluate whether it has helped you to reduce your tics over the past 
12 months or whether it has helped you in other areas such as your 
satisfaction with your life or your ability on certain thinking tasks as well as 
your attendance at school. Afterwards, we would let you know if the groups 
helped you in terms of any of the areas we have evaluated.  
 
Once the study is finished we will invite you and your family to a 
feedback session where we will explain the results of the study and what 
we have learnt. 
 
What will I be asked to do if I take part? 
 
 
 We will arrange a meeting with you and your parents at your home, which 
should last about 3 hours. 
 We’ll spend this time doing puzzles and asking you some questions. 
 
 We will ask you to do a selection of different things and hope you will find 
them interesting.  
 During the visit we would ask you to watch a DVD for 20 minutes 
and make a film of you as you watch it. For five minutes we would 
also ask you to try to tic as little as you can.  
 You would be able to have short breaks if you feel tired or to stop if you 
want to. 
 We would also ask your parents or carers some questions.  
 
Is there anything to be worried about if I take part? 
 
When we do the games and puzzles you can take breaks if you get tired. 
If you are upset by taking part in the study, please speak to your parents 
about it. If you would like to speak to someone else, your parents know 
how to contact us and our address and phone number are at the end of 
this sheet. Your treatment at  will not be 
changed by taking part or not taking part in the study. 
 
Who will know I am taking part in the study? 
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We would keep your name, address and your results from the games 
and puzzles secret. We will write about the study but no names will be 
used. If you agreed then we would write to your doctor to let them know 
you are taking part. 
 
What will happen to the results of the study? 
The results of the 12-month follow-up visit will not be known until about 
September 2015. We hope to organise a time to tell everyone about the 
study soon after that, which you would be invited to. 
 
Who do I speak to if I have further questions or worries? 
Your parents also have information about this study. You can ask them 
questions. You can contact  if you have any other 
questions. 
 
Contact:   , Consultant Clinical Psychologist 
 
Address:  
 
  
  
  
  
 
 
Email:      
 
Tel:          
 
Supervised by: , Consultant Clinical Psychologist,  
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Appendix N: Visual plan of the day 
 
PLAN FOR TODAY 
 
 3 forms 
 Computer games x 2 
 Peg game 
 2 forms 
 Games and puzzles 
 Watching a Simpsons episode 
 Trying to hold in your tics for 5mins  
bouncy ball REWARD!  
 Talking together with your 
parents/carers about your tics this week 
 1 form 
THE END 
THANK YOU!   
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Appendix O: Parent consent form 
 
 
 
 
 
 
Identification Number_______ 
 
CONSENT FORM FOR PARENTS/ GUARDIANS 
Title of Project: Follow-up to a Randomised pilot study evaluating two group 
therapies for Tourette Syndrome  
 
Names of Researchers:  Julia Dabrowski, Trainee Clinical Psychologist 
         , Consultant Clinical Psychologist 
         , Consultant Child Psychiatrist 
 
1. I confirm that I have read and understood the information sheet 
for the above study. I have had the opportunity to consider the 
information, ask questions and have had these questions 
answered satisfactorily. 
 
 
 
2. I understand that my child’s participation is voluntary and that I 
am free to withdraw at any time, without giving any reason, 
without medical care or legal rights being affected. 
 
 
 
3. I agree to my child being videoed for the purpose of the study. 
 
4. I understand that relevant sections of my child’s medical notes 
and data collected during the study may be looked at by 
responsible individuals from regulatory authorities or the NHS 
trust, where it is relevant to their taking part in this research. I 
give permission for these individuals to have access to my 
child’s records. 
  
5. I agree to a researcher contacting my child’s school in order to 
obtain their school attendance rate. 
 
 
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Version and date of the participant information sheet that the parent/carer has 
read:________ 
Please initial the box after each statement. 
 
Name of Child______________________  
 
 
Name of Parent or Guardian    Date       Signature 
 
______________________     ____________        ________________ 
Researcher  
 
______________________     ____________        ________________ 
                              
 
 
 
 
6. I understand that the videos will be encrypted and stored on 
password protected computers. They will be permanently 
erased once they have been viewed by the researchers, in line 
with data information governance and the law.  
 
 
 
7. I understand that while participating in the study my child will 
be unable to receive any individual psychological treatment, 
but that should they require this, we will be able to withdraw 
from the study at any time. 
 
 
 
8. I understand that sections of my child’s medical notes may be 
looked at by the researchers where it is relevant to my taking 
part in the study. I give permission for these individuals to have 
access to my child’s records. 
 
 
9. I agree to my child’s GP being informed of their participation in 
the study.  
10. I agree to participate in the above follow-up study.  
 
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Appendix P: Child assent form 
 
 
 
 
 
 
 
Identification Number_______ 
 
PARTICIPANT ASSENT FORM 
Title of Project: Follow-up to a Randomised pilot study evaluating two group therapies 
for Tourette Syndrome  
 
Names of Researchers:  Julia Dabrowski, Trainee Clinical Psychologist 
         , Consultant Clinical Psychologist 
         , Consultant Child Psychiatrist 
 
Please circle YES or NO 
 
Have you understood the information you were given?         YES   NO 
 
Have you understood that we would video you as part of      YES  NO 
the study? The videos would be deleted once we have  
used them and will not be viewed by anyone except the  
researchers. 
 
Have you understood that we would contact your school       YES  NO 
to obtain a school attendance record?    
 
Have you been able to ask questions and had them              YES  NO 
answered? 
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Would you like to take part?               YES  NO 
 
Do you understand that you can stop being involved            
in the study at any time you like?      YES  NO 
 
 
____________________ ____________        _______________________ 
Name    Date   Signature 
 
____________________ __________           _______________________ 
Researcher       Date   Signature 
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Appendix Q: Mixed model Repeated Measures Analysis of Variance (RM-ANOVA) tests analysing the effects of time (T1, T2, T3) and group 
condition (PE and CBIT) on tic severity 
 
 PE (N = 13) CBIT (N = 15) Main 
effect of 
group 
Main 
effect of 
time 
Interaction All (N = 28) 
 T1 T2 T3 T1 T2 T3    T1 T2 T3 
 M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
p p p M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
YGTSS             
 Motor 15.92 
(3.23), 
13.97 – 
17.87 
15.54 
(2.33), 
14.13 – 
16.95 
13.77 
(4.46), 
11.08 – 
16.46 
17.60 
(4.53), 
15.09 – 
20.11 
14.73 
(3.83), 
12.61 – 
16.85 
12.20 
(5.07), 
9.39 – 
15.01 
0.86 <0.001** 0.07 
 
16.82 
(4.00), 
15.27 – 
18.37 
15.11 
(3.19), 
13.87 – 
16.34 
12.93 
(4.78), 
11.08 – 
14.78 
 Phonic 12.92 
(6.41), 
9.05 – 
16.80 
11.15 
(6.35), 
7.32 – 
14.99 
9.23 
(7.28), 
4.83 – 
13.63 
12.33 
(7.19), 
8.35 – 
16.31 
12.33 
(5.64), 
9.21 – 
15.46 
10.00 
(7.10), 
6.07 – 
13.93 
0.84 0.013** 0.66 12.61 
(6.72), 
10.00 – 
15.21 
11.79 
(5.90), 
9.50 – 
14.07 
9.64 
(7.06), 
6.90 – 
12.38 
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 PE (N = 13) CBIT (N = 15) Main 
effect of 
group 
Main 
effect of 
time 
Interaction All (N = 28) 
 T1 T2 T3 T1 T2 T3    T1 T2 T3 
 M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
p p p M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
 Tic 
Severity 
28.85 
(8.70), 
23.59 – 
34.10 
26.69 
(7.50), 
22.16 – 
31.22 
23.00 
(10.83), 
16.45 – 
29.55 
29.93 
(10.05), 
24.37 – 
35.50 
27.07 
(8.44), 
22.39 – 
31.74 
22.20 
(10.84), 
16.20 – 
28.20 
0.946 >0.001** 0.791 29.43 
(9.29), 
25.83 – 
33.03 
26.89 
(7.87), 
23.84 – 
29.94 
22.57 
(10.64), 
18.45 – 
26.70 
 Total tic 
score 
49.62 
(16.08), 
39.90 – 
59.33 
46.69 
(13.15), 
38.75 – 
54.64 
43.77 
(17.27), 
33.33 – 
54.21 
52.60 
(15.57), 
43.98 – 
61.22 
41.73 
(14.04), 
33.96 – 
49.51 
39.53 
(18.04), 
29.55 – 
49.52 
0.695 0.002** 0.235 51.21 
(15.59), 
45.17 – 
57.26 
44.04 
(13.62), 
38.76 – 
49.32 
41.50 
(17.49), 
34.72 – 
48.28 
** Significant result that survives Bonferroni correction (0.05/4 = 0.013). 
 Appendix R: Results from a series of 2 X 2 RM-ANOVA tests analysing the effects 
time (T2 and T3) and group condition (PE and CBIT) on tic severity 
 
 
 Psych-Ed (N = 13) CBIT (N = 15) Main 
effect 
of 
group 
Main 
effect of 
time 
Inter-
action 
 T2 T3 T2 T3    
YGTSS M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
M (SD), 
95% CI 
p p p 
Motor 
tic 
severity 
15.54 
(2.33), 
14.13 – 
16.95 
13.77 
(4.46), 
11.08 – 
16.46 
14.73 
(3.83), 
12.61 – 
16.85 
12.20 
(5.07), 
9.39 – 
15.01 
0.382 0.011** 0.630 
Phonic 
tic 
severity 
11.15 
(6.35), 
7.32 – 
14.99 
9.23 
(7.28), 
4.83 – 
13.63 
12.33 
(5.64), 
9.21 – 
15.46 
10.00 
(7.10), 
6.07 – 
13.93 
0.670 0.059 0.851 
Total tic 
severity 
26.69 
(7.50), 
22.16 – 
31.22 
23.00 
(10.83), 
16.45 – 
29.55 
27.07 
(8.44), 
22.39 – 
31.74 
22.20 
(10.84), 
16.20 – 
28.20 
0.715 0.012** 0.948 
YGTSS 
total 
score 
46.69 
(13.15), 
38.75 – 
54.64 
43.77 
(17.27), 
33.33 – 
54.21 
41.73 
(14.04), 
33.96 – 
49.51 
39.53 
(18.04), 
29.55 – 
49.52 
0.394 0.364 0.897 
** Significant result that survives Bonferroni correction (0.05/4 = 0.013). 
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